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ABSTRACT
Results of the Leucocyte Migration Inhibition
(LMI) test with gluten in adult coeliac disease are
shown to be affected by the histocompatibility antigen
HLA-B8. Normal subjects with B8 show greater immunity
than those lacking B8 and give similar results to
untreated coeliacs. B8 and non-B8 coeliacs give
similar results. A gluten-free diet produces an early
increase in immunity in coeliacs with a later decline.
Production of migration inhibitory factors in blood and
by jejunal mucosa are inversely correlated. Untreated
coeliacs give positive responses in the LMI test to
several dietary antigens similar in magnitude and
prevalence to those seen with gluten. These responses
are uninfluenced by HLA-B8 and do not increase after
gluten exclusion. Results of the LMI test with gluten
are unaffected by puromycin and results of the test
performed with purified polymorphs are similar to and
correlate with results of the standard test. Added T
lymphocytes have no effect. These results contrast
with those seen with PPD as antigen. Normal leucocytes
can be sensitised to gluten by coeliac serum and this
sensitisation can be blocked by IgG, suggesting that
migration inhibition is mediated by cytophilic antibody
and not T cell produced lvmphokines.
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Jejunal mucosal biopsies from treated coeliac
patients are co-cultured with autologous blood
mononuclear cells. These biopsies show no significant
damage with gluten or lymphocytes alone but
quantitative histology shows evidence of toxicity when
biopsies are cultured with gluten and lymphocytes
together. Phosphatidyl inositol turnover in cultured
biopsies is measured to try and detect a lectin-like
effect of gluten but shows no difference between
coeliacs and controls.
The findings are discussed and the relevant
literature is reviewed.
INTRODUCTION
is a capital mistake to theorize before
one has data"
The Adventures of Sherlock Holmes
Sir Arthur Conan-Doyle, 1891.
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History
The word coeliac is derived from the Greek
" koiliakos" which means "belonging to the belly; also,
suffering in the bowels" (Oxford English Dictionary,
1971). It is perhaps in the latter sense that the word
was used by Aretaeus in what seems to be the earliest
description of the malabsorption syndrome. Aretaeus is
a rather mysterious figure who practised medicine in
Cappadocia in Asia Minor in the second century A.D.
(Major, 1948). He was thus a contemporary of Galen and
in view of his remarkably accurate descriptions of
diseases as diverse as diabetes mellitus, epilepsy,
asthma, gonorrhoea and elephantiasis it is surprising
that his name is not better known. His essay "On the
Coeliac Affection" (translated by Francis Adams, 1856)
contains a description of steatorrhoea and the effects
of malabsorption of food on children and adults. His
ideas on therapy are, as one might expect, strange to
us. Aretaeus recommends astringent wines, the stones
of unripe grapes and digestive medicine made from
vipers. However, he also suggests that "the stomach is
to be relieved from its suffering by rest and
abstinence from food, for in this way the natural
powers are restored". At one point, Aretaeus uses the
word "siton" for food. A standard Greek-English
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dictionary (Liddell & Scott, 1869) defines this word as
"food made of wheat or corn" and this, together with
Aretaeus1 comment that "bread alone contributes little
towards strength" raises the possibility that the
harmful effects of wheat products on coeliac patients
may have been noticed almost two thousand years ago.
The next classic description of coeliac disease
was that of Samuel Gee (Gee, 1888). Once more several
passages seem strangely perceptive: "The allowance of
farinaceous foods must be small","if the patient can be
cured at all it must be by means of diet". Despite
these early observations and the use of low carbo¬
hydrate diets to treat coeliacs in the early part of
this century (Haas, 1932; Sheldon, 1949) it was not
until after the Second World War that Dicke, first in
his M.D. thesis and then in a series of papers (Dicke,
1950; 1953) demonstrated the dramatic effect of
excluding wheat, rye and oats from the diet of coeliac
children. At about the same time the pathological
lesion of coeliac disease was described by Paulley in
specimens of small bowel taken at laparotomy (Paulley,
1954). Within a few years workers on both sides of the
Atlantic had devised methods for peroral biopsy of the
mucosa of the duodenum and proximal jejunum (Palmer,
1953; Shiner, 1956a; Shiner, 1956b; Crosby, 1957;
Brandborg et al . 1959 ) and the diagnosis of coeliac
disease entered the modern era.
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Definition of Coeliac Disease
Early definitions of coeliac disease were
essentially those of a clinical picture of
malabsorption of unknown cause. By the 1950s it was
being suggested that it was necessary to demonstrate a
raised faecal fat excretion (Cooke, Peeney & Hawkins,
1953) though it was later shown that in fact patients
with untreated coeliac disease may have a normal stool
fat (Gent & Creamer, 1968). Paulley's description of
the typical histological abnormalities (Paulley, 1954)
together with the development of techniques for peroral
jejunal biopsy have led to much greater precision. The
typical histological abnormalities are well known.
They consist of:
1) Total or almost total loss of villi (Shiner &
Doniach, 1960)
2) Hypertrophy of the crypts (Rubin et al .
1960a)
3) Abnormalities of the epithelial cells: the
enterocytes tending towards a cuboidal rather
than the normal columnar shape (Yardley et
al. 1962)
4) Infiltration of the mucosa with lymphoid
cells; in particular, an increase in the
number of lymphocytes in the epithelial cell
layer (Ferguson & Murray, 1971).
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In 1967 Pink & Creamer stated that "any condition
with a flat jejunal mucosa" constituted the coeliac
syndrome and required treatment with a gluten-free diet
and Cooke (1968) considered that "the histologically
flat jejunal mucosa with mosaic pattern on dissecting
microscopy is specific for coeliac disease", confirming
earlier ideas that the flat biopsy was diagnostic
(Rubin et al . 1960a; Cameron et al . 1962 ). This view,
however, has proved untenable as a wide variety of
conditions have been described in which subtotal
villous atrophy has been found (see Table 1).
Weinstein and his colleagues (Weinstein et al. 1970)
proposed two essential criteria:
1) A characteristic flat biopsy at the
duodenojejunal junction in a patient with
malabsorption
2) An unequivocal clinical response to a
gluten-free diet.
This too has proved unsatisfactory as it is
difficult to judge what constitutes an "unequivocal
clinical response", especially in those patients who
are virtually symptom-free and without steatorrhoea.
There is also evidence that gluten exclusion may
produce clinical improvement in tropical sprue (Bayless
& Swanson, 1964) and regional enteritis (Rudman et al.
TABLE 1
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1971). The strictest criteria for diagnosis are those
laid down by the European Society for Paediatric
Gastroenterology (Meeuwisse, 1970) who require a
complete restitution to clinical and histological
normality with gluten exclusion followed by relapse of
the mucosa on gluten challenge. Booth (1974) has
proposed a similar definition for adult coeliac disease
though without demanding a return to normality on a
gluten-free diet.
While these last two definitions seem most
suitable for scientific studies of coeliac disease,
there are practical problems. Gluten challenge is not
without hazard and one death has been reported (Neale,
1968). Booth himself, in discussion, stated that
"there is no need to challenge most (adult) patients"
(Booth, 1974).
In this study, therefore, patients are accepted as
having coeliac disease if the initial jejunal biopsy
taken whilst the patient is on a normal qluten-
containing diet shows the characteristic abnormalities
outlined above and if a subsequent biopsy, taken after
a period of gluten exclusion, shows definite
histological improvement. A few patients were also
accepted as coeliacs who had been taking gluten-free
diets for some time without a previous satisfactory
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biopsy. These patients were all biopsied whilst on a
gluten-free diet, put onto a gluten-containing diet and
re-biopsied between three and five months later, or
earlier if symptomatic. Clear histological
deterioration was accepted as evidence of coeliac
disease.
As a final point, it is worth noting that recent
studies of high gluten diets in both relatives of
coeliac patients and in patients with altered immunity
have suggested that significant histological changes
can be produced in previously normal mucosa (Doherty &
Barry, 1981). Future definitions of coeliac disease
may have to be modified to take account of these
findings if they are confirmed.
Pathogenesis of the mucosal lesion
The search for the toxic fraction
Once the deleterious effect of wheat on
coeliac patients had been established the search for
the toxic factor began. Dicke et a 1 . (1953) pointed
out that wheat flour was harmful but wheat starch was
not and the same workers showed that the toxic factor
was found in the protein component and, more
specifically, the gliadin fraction of the flour. (van
de Kamer et al . 1953 ). Wheat flour consists of the
milled endosperm of the wheat grain. About 75% of the
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flour is starch, 7-15% is protein, 1-2% lipid and the
remainder is water with variable amounts of hemi-
celluloses (Ewart, 1970). Gliadins are separated from
the other proteins (albumin, globulin and glutenin) on
the basis of being alcohol-soluble and can be separated
into a, p and y gliadins by starch-gel electro¬
phoresis. A1pha-gliadin is the most readily
extractable protein and has been widely tested in
toxicity studies (Hekkens et a1. 1970). It is not,
however, a single protein (Bernardin et al . 1967 ) and
seems to be composed of similar polypeptide units to
the other gliadins (Patey et al. 1975). Efforts to
produce wheat which was non-toxic led to a variety of
wheat (multisomic 6A tetrasomic 6D) which produced very
little a-gliadin but normal amounts of p and y gliadin
(Kasarda et al. 1978). Sadly, this wheat proved no
less deleterious than normal to coeliac patients
(Ciclitira et al. 1981).
Frazer et al. (1959) utilised a different approach
by performing a peptic-tryptic digest of gluten. It
had previously been observed that complete acid
hydrolysis of gluten rendered it non-toxic to children
with coeliac disease (Alvey et al. 1957; Weijers & van
de Kamer, 1958). Frazer and his colleagues stopped
their proteolytic digestion short of complete
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hydrolysis to produce a water-soluble heterogenous
material consisting mainly of polypeptides of molecular
weight less than 15,000. This material (the well-known
gluten fraction III) was shown to retain the toxicity
of untreated gluten by clinical testing. The most
extensive series of experiments in search of the toxic
fragment have been carried out with gluten fraction III
as a starting material and have come from the Oxford
group. Dissanayake and colleagues (1974) separated
gluten fraction III into three subtractions, A, B and
C, on the basis of molecular size by ultrafiltration
through a series of membranes. Toxicity was then
tested in three coeliac patients and assessed by
repeated jejunal biopsy. The fractions containing the
larger molecules (B and C) both proved toxic; fraction
A, consisting of ami no-acids and oligopeptides with
molecular weights of under 1,000, was innocuous.
Fraction B, consisting of polypeptides with a mean
molecular weight of about 8,000, was further separated
to subtractions Bl, B2 and B3 by gel filtration through
a Sephadex G50 column. Feeding experiments showed
toxicity residing in the B2 and B3 fractions (Sikora et
al. 1976). The B2 fraction had a smaller mean
molecular weight than B3, with a mean in the high
hundreds (Offord et al . 1978 ) and as the point of the
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experiments has been to identify the smallest peptides
which retain toxicity, it is this fraction which has
been most used in further studies.
A similar approach to that of the Oxford group,
that is proteolytic digestion followed by separation by
ge 1 -fi1tration , has been used by several groups with
gliadin rather than gluten as the starting material
(Bronstein et al. 1966; Cornell & Townley, 1973a;
Hekkens et al . 1974). Hekkens and his colleagues
(1974) produced a-GT 18,000 from a tryptic digest and
this was found to be toxic in vivo and to react with
rabbit anti-a-gliadin serum. Cornell & Townley (1973a)
produced the more extensively studied fraction 9 from a
peptic-tryptic-pancreatinine digest and this toxic
fraction has been further subfractionated by gel-
filtration to yield materials of mean molecular weight
around 1,500 and which are rather confusingly termed
fractions IB and 2B (Cornell & Rolles, 1978).
Jos and his colleagues (Jos et al., 1982) using
gel filtration of digests of p-gliadin have produced a
peptide (" P5") of molecular weight around 7000 shown to
be toxic in organ culture studies. Further work on yet
smaller fragments of both a-gliadin and B2 has been
started (Kasarda et al. 1974; Anand et al. 1977) which
includes some preliminary work on amino-acid
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sequencing. This may be a little premature as these
smaller fractions have not yet been adequately tested
for toxicity in vivo, but clearly, if" indeed there is a
single peptide which causes the mucosal damage in
coeliac disease, then it is likely to be identified and
characterised within the foreseeable future.
Carbohydrate Content & Toxicity
One group of workers have taken an original
and interesting view of the problem of finding the
toxic fraction. Phelan and his colleagues from Galway
have pointed out that all attempts to abolish the
toxicity of gluten by proteolytic enzymes have failed
(Phelan et al. 1974). They postulated that the
explanation for this fact was not that toxicity resided
in a small peptide resistant to proteolysis, but that
toxicity may be due to a carbohydrate moiety in the
protein. In a series of experiments gliadin was
therefore treated with carbohydrases produced from the
fungus Aspergillus niger and the resulting material was
found to be non-toxic in feeding experiments in a small
group of coeliac patients (Phelan et al . 1974 , 1977 ,
1978; Stevens, Phelan, McNicholl et al. 1978). Peptide
mapping of the treated gliadin showed no differences
from untreated gliadin (Phelan et al . 1974 ) and no
evidence of proteolytic activity in the carbohydrases
could be found (Phelan et al . 1978).
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Fascinating as these results are, it should be
emphasised that they have been criticised on the way in
which toxicity was assessed with regard to the small
numbers of patients used in the feeding experiments,
the differences in initial histology between those
given treated and untreated gliadin and the duration of
the challenge. Furthermore, Bernard in et a 1 . (1976)
failed to demonstrate a significant amount of carbo¬
hydrate in a gliadin preparation which was toxic. The
concept, however, is interesting and far from being
disproven, and has relevance to some of the theories of
the mechanism of toxicity which are discussed later.
Assessment of Gluten Toxicity
The investigation of the nature of the toxic
fraction of gluten, and of the mechanisms by which
gluten may be damaging the small bowel mucosa requires
a system in which toxicity may be tested and
quantified, and in which various pharmacological or
immunological modifications may be made to attempt to
modify the toxicity shown. Furthermore, such a test
system should not involve risk to the health of
patients.
As indicated in the previous section, the basic
technique used has been feeding of the material under
test to coeliac patients and monitoring their
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response. Initially this consisted simply of observing
clinical status (Dicke et al. 1953) and later by
measurements of faecal fat (Fraser et al . 1959 ). More
sophisticated methods of assessing the integrity of
absorptive function have been devised and proposed as
screening procedures for the diagnosis of coeliac
disease, for example xylose absorption (Rolles et al.
1975) and intestinal permeability as assessed by the
absorption of two molecules of different sizes (Cobden
et al . 1978 ). The former has been used as a test for
gliadin toxicity (Stevens, Watt, Bourke et al . 1978 )
but has not gained widespread acceptance. As the
definition of coeliac disease rests on histological
criteria, it seems appropriate to adopt histological
methods to test for gluten toxicity and indeed this has
been widely done by repeated jejunal biopsies either
after a period of gluten feeding (Bayless et al. 1970;
Dissanayake et al. 1974; Sikora et al. 1976) or after
installation of the material directly into the small
bowel or duodenum (Shmerling & Shriver, 1970; Hekkens
et al . 1970 ; Anand et al . 1981).
All these methods of testing in patients, however,
involve discomfort to the patient and some minor risk,
as gluten challenge may provoke irreversible
deterioration (Neale, 1968). Large amounts of test
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material are required for in vivo testing and repeated
testing and experimental use of pharmacological or
immunologically active agents is impractical. Attempts
have thus been made to develop in vitro test systems.
Some workers have claimed that fraction 9 of
g1iadin causes increased acid phosphatase release from
rat liver lysosomes (Cornell & Townley, 1973b; Townley
et al . 1973 ) though this has not been confirmed by
others using gliadin or Frazer's fraction III (Hekkens,
1978 ). Cordone et al . ( 1975 ) used fibroblasts from
coeliac patients as a target and claimed that gluten
caused degeneration but, again, this has not been
confirmed (Hekkens, 1978). The loqical target to use
in assessing gluten toxicity is, of course, the jejunal
mucosal epithelial cell as this seems to bear the brunt
of gluten-induced damage in vivo. As yet there is no
satisfactory system for isolating and culturing these
cells, but organ culture of fragments of jejunal mucosa
is perhaps the next best thing and has proved
technically feasible.
Jejunal Mucosal Organ Culture in Coeliac Disease
In 1969 Browning & Trier described a
technique with which it was possible to maintain human
small intestinal mucosal biopsies in organ culture for
24 hours with good preservation of the mucosal
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architecture. The same authors later reported that
epithelial cells of biopsies from patients with
untreated coeliac disease which were cultured for 24
hours in gluten-free medium showed morphological
improvement as assessed by electron microscopy (Trier &
Browning, 1970). Subjective improvement in morphology
has also been found after culture in gluten-free medium
by other workers (Falchuk et al . 1974; Jos et al. 1975 ;
Hauri et al . 1978). Townley et al . ( 1973 ), Falchuk et
al. (1974) and Jos et al. (1975) all showed that this
improvement could be prevented by incorporation into
the culture medium of gluten peptides known to be toxic
in vivo, though Jos also showed some toxic effect of
casein peptides on untreated coeliac biopsies, and
Hauri et al. (1978) could demonstrate no in vitro
toxicity of gluten fractions shown to be toxic in vivo.
However, all these studies relied on subjective
assessment of improvement in histology which may be
imprecise. Falchuk et al. (1974), however, also
measured mucosal alkaline phosphatase activity in the
cultured biopsies and demonstrated a marked rise (from
an initially low value) of enzyme activity in untreated
coeliac biopsies cultured in the absence of gluten, and
abolition of this rise by culture with gluten
peptides. Casein peptides had no significant effect.
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In 1978 Katz & Falchuk reported use of the technique to
predict gluten sensitivity in a group of patients
taking a normal diet who had abnormal biopsies, and in
1980 the same group (Falchuk et al. 1980) again showed
in vitro gluten sensitivity in untreated or gluten-
challenged patients and further suggested that
responses in their system depended on histo¬
compatibility type, being most marked in patients
having the HLA-B8 antigen, and have also produced
interesting results on co-culture of biopsies from
treated and untreated patients (Falchuk, Gebhard &
Strober, 1974) and on the effect of corticosteroid on
the in vitro toxicity of gluten (Katz et al. 1976)
which will be discussed in more detail later.
This method of assessing in vitro toxicity has
not, however, been unchallenged. Hauri et al . ( 1978 )
could show no effect of gluten on brush border enzyme
activities (including alkaline phosphatase). Stevens,
Keane & Fottrell et al. ( 1978 ) and Mitchell et al .
(1974) were unable to demonstrate a rise in alkaline
phosphatase in biopsies cultured in the absence of
gluten and the latter workers also criticised the
expression of results in relation to the protein
content of the biopsy, as they showed that the protein
content per wet weight of the biopsy declined with
increasing culture time.
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A more recent study (Howdle et al . 1981) has
utilised another approach. These workers felt that as
the criterion for the diagnosis of coeliac disease is
histological then histology is the most appropriate
method of assessing in vitro gluten toxicity. Rather
than rely on subjective assessment, however, they used
objective measurement of enterocyte height as an index
of mucosal damage and demonstrated that enterocyte
height of biopsies from untreated patients rose during
culture in gluten-free medium and that this rise was
prevented by gluten fraction III but not by casein.
Rapid changes in enterocyte height in vivo have been
observed in coeliac disease following dietary
modification (Yardley et al. 1962; Bayless et al.
1970). Fluge & Asknes (1981) have produced similar
results to Howdle et al. and this method of assessing
gluten toxicity in vitro seems likely to prove useful.
Another important finding from these in vitro
studies has been the relative insensitivity of biopsies
from coeliac patients who had been treated by gluten-
exclusion to gluten toxicity in vitro. Falchuk and his
colleagues (Falchuk et al. 1974; Falchuk, Gebhard &
Strober, 1974) were unable to demonstrate any effect of
gluten peptides on treated mucosa in vitro using
biochemical assessent, though sensitivity to gluten was
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restored by co-culture with an untreated biopsy
(Falchuk, Gebhard & Strober, 1974). Fluge & Asknes
(1981), using quantitative histology, also failed to
show any effect of gluten on treated biopsies, though
Howdle et al . (1981) did show a slight but significant
decrease in enterocyte height of treated biopsies when
cultured with gluten fraction III. This decrease was,
however, much less than the changes seen with untreated
biopsies. Possible explanations for this difference in
sensitivity include activation of some endogenous
effector mechanism which is more active in untreated
than treated mucosa, and the difference does argue
against a direct toxic effect of gluten.
In summary, after over a decade of experience with
organ culture studies in coeliac disease, there is
still disagreement as to the best method of assessing
mucosal damage. Despite this, there is considerable
agreement between different groups using different
systems that gluten sensitivity can be demonstrated
using biopsies from untreated coeliac patients and that
this sensitivity is less or absent in biopsies from
treated patients. The organ culture system obviously
offers great scope for unravelling the mechanisms of
gluten toxicity, but apart from the co-culture and
steroid experiments of Falchuk and co-workers mentioned
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above, there has been little exploitation of the
possibility of varying different factors in the system
in order to investigate the importance of possible
mechanisms of toxicity.
Mechanism of Gluten Toxicity
I. The Digestive Enzyme Deficiency Theory
The suggestion that patients with coeliac
disease have an inborn error of metabolism which
results in a deficiency of an intestinal digestive
enzyme necessary for the complete digestion of gluten
dates back to the work of Frazer (1956). Lack of the
putative enzyme causes damage to the intestine by
allowing the accumulation of a toxic fraction of gluten
which in normal people is digested further and rendered
harmless. Frazer demonstrated that a peptic-tryptic
digest of gluten known to be toxic to coeliac patients
in vivo could be made non-toxic by incubation with
normal pig intestinal mucosa. Further evidence in
favour of this theory has come from studies of the
ability of homogenates of intestinal mucosal biopsies
from coeliac patients to digest gluten in vitro. An
early study of this type (Douglas & Booth, 1970) showed
no difference in either the amount of amino-acids
liberated or of peptides remaining after incubation
with mucosal homogenates from coeliacs or from
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controls. Cornell & Townley (1973) repeated this work,
however, and by using a smaller fraction as substrate
(fraction 9), increasing the mucosal protein to
substrate ratio and prolonging the incubation time,
they demonstrated a lesser degree of digestion of
fraction 9 by coeliac mucosa than by normal mucosa.
Residual peptides showed a high content of glut amine,
proline and serine and they suggested that a peptidase
involved in hydrolysing this combination of amino acids
was deficient. Similar results were reported by
Carchon et a 1 . (1979) using biopsies from children with
coeliac disese. Later work (Cornell & Rolles, 1978)
confirmed these findings and also suggested a partial
deficiency of the same peptidase in first degree
relatives of coeliac patients.
A parallel approach has been to measure intestinal
peptidase activity directly. There have been several
studies of this type (Messer et al . 1961; Fottrell et
al. 1970; Berg et al. 1970; Scott, 1975) which have
failed to demonstrate any significant differences
between control and treated coeliac mucosa. Earlier
work demonstrating lower dipeptidase activity in
coeliac mucosa with an improvement following treatment
(Lindberg, Norden & Josefroon, 1968) has been
criticised as merely representing villous atrophy in
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the coeliac patients (Fottrell et al . 1970 ) and indeed
the same criticism can be levelled at any studies
comparing coeliac and normal mucosa even if the coeliac
mucosa seems normal histologically as enzyme recovery
may lag behind histological recovery. More recent work
(Sterchi & Woodley, 1978) has shown that peptidases in
highly purified brush border membranes from normal
human intestinal mucosa have broad specificity and are
thus able to digest a range of substrates and suggest
that this renders an enzyme deficit in coeliac disease
unlikely, though a direct comparison with coeliac
mucosa was not made.
Some circumstantial evidence in favour of the
enzyme theory comes from observations of early damage
to the epithelial cell after gluten challenge (Bayless
et al . 1970; Dissanayake et al. 1974 ) as it is
suggested that such damage (within six hours) could not
be mediated via immunological mechanisms. This
argument, however, is not convincing as immune complex,
cytotoxic T cell or antibody-mediated cellular
cytotoxic reactions may all be evident in this time
scale.
As this thesis offers no evidence directly
relating to possible digestive enzyme defects, the
topic will not be discussed further. However, the
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theory remains with us as (1) it is virtually
impossible to disprove and (2) it is not incompatible
with the immunological and lectin theories discussed
below as the immunogen or lectin implicated in these
theories may well represent an abnormal product of
digestion.
11. The Immunological Theory
The basic thesis of the immunological theory
of the pathogenesis of coeliac disease is that patients
with coeliac disese have an exaggerated or aberrant
immune reaction to a component of gluten and that this
abnormal immune reaction results in damage to the
jejunal mucosa.
The small intestine is a major lymphoid organ,
which is unsurprising when one considers the enormous
antigen load handled by the gut. Numerous alterations
of immune function have been observed in coeliac
disease. It is, however, difficult to establish whether
these various abnormalities have a primary role in
causing the mucosal damage or whether they are merely
epiphenomena secondary to the mucosal damage.
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Evidence relating to the Immunological Theory
1. Non-specific abnormalities of the immune
system
A number of immunological changes not
particularly concerned with specific immunity to gluten
have been described in coeliac disease.
a) Morphological Changes
Several morphological features of coeliac
disease have been thought relevant to the
immunological theory. These include the
increased numbers of lymphoid cells in the
lamina propria and epithelial cell 1ayer of
the jejunum (Paulley, 1954; Ferguson &
Murray, 1971); mesenteric node hypertrophy
(Paulley, 1954); peripheral node hypoplasia
(McCarthy et al . 1966 ); splenic atrophy
(McCarthy et al. 1966) and the increased
incidence of lymphoreticular malignancies in
coeliac disease (Harris et al . 1967; Barry &
Read, 1973; Holmes et al . 1976; Isaacson,
1980) .
b) Changes in Lymphoid Cell Count
Counts of total blood lymphocytes in coeliac
disease have given conflicting results
(Brandt & Stensham, 1975 ; O'Donoghue et al .
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1976 ; Bui Ten & Losowsky, 1977 ). The number
of circulating T lymphocytes, however, does
seem to be reduced in untreated coeliacs
(O'Donoghue et a 1 . 1976) especially those
with hyposplenism (Bullen & Losowsky, 1977),
and to rise following gluten withdrawal
(O'Donoghue et al. 1976).
The increase in intraepithelial lymphocytes
and of plasma cells in the lamina propria of
the jejunal mucosa of untreated coeliacs
mentioned above has been quantitated by
several groups and both parameters return
towards normality on gluten withdrawal
(Ferguson & Murray, 1971; Lancaster-Smith et
al. 1976; Mavromichalis et al . 1976 ).
It is perhaps worth observing that the
assessment of the degree of infiltration of
the intestinal epithelium by lymphocytes
depends on how the result in expressed. Most
studies express lymphocyte counts per 100
epithelial cells and show an increase in
lymphocytes in untreated coeliac disease.
Marsh (1980) expressed his counts relative to
unit area of muscular is mucosae and found
decreased lymphocyte counts in untreated
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coeliac disease with an increase to normal on
gluten withdrawal. He also observed that the
lymphocytes in coeliac biopsies were larger
and had increased mitotic activity.
Both animal studies (Ropke & Everett, 1976;
Guy-Grand et al . 1974) and human studies
(Meuwissen et al . 1976 ) have suggested that
most intraepithelial lymphocytes are T cells
and recent work suggests that most have the
surface markers of suppressor-cytotoxic cells
in contrast to lamina propria lymphocytes
where less than 40% bear such markers (Selby
et al. 1981).
c) Changes in Serum Immunoglobulins
There is a large literature on this topic,
which is perhaps surprising as total serum
immunoglobulin levels seem unlikely to
provide any very helpful information as
regards pathogenesis. In general, the
findings have been of normal or low IgM and
IgG in untreated coeliacs, with a reversion
towards normality on treatment by gluten-free
diet (Asquith et al. 1969; Baklien et al.
1977 ). Serum IgE levels seem to be normal,
though IgD deficiency has been reported to be
common (Asquith et al. 1969).
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Perhaps the most notable finding has been the
increased incidence of I g A deficiency in
coeliac patients (Hobbs & Hepner, 1968;
Asquith et al. 1969). Most of these patients
seem to respond to gluten withdrawal, unlike
patients who have a flat jejunal biopsy with
generalised hypogammg1obu1inaemia where the
relation to gluten is not clear and where
chronic infection may be important in
producing the mucosal lesion (Ross & Asquith,
1979 ) .
Intestinal Immunoglobulin Production
Raised immunoglobulins of IgM, I g G and IgA
class have been reported in intestinal
secretions of coeliac patients (Hobbs et al.
1969; Asquith, Thompson & Cooke, 1970) but
the significance of this is unclear. Results
of immunofluorescent counts of lamina propria
plasma cells have given conflicting results
(Brandtzaeg & Baklien, 1976). In general,
there seems to be an increase in IgM and IgG




Baker et al. (1975) showed impaired primary
and secondary antibody responses in coeliacs
following immunisation with the bacteriophage
0X174. Switching of Ig M to I g G during the
secondary response was impaired and the
abnormalities shown were more prominent in
those patients with hyposplenism. Beale et
al. (1971) found normal responses to tetanus
toxoid but impaired response to oral polio-
virus vaccine. Mawhinney & Love (1975),
however, found increased Ig A and IgG
responses to oral polio vaccine in coeliacs.
These results suggest some alteration in
modulation of immune function and may be
related to the high prevalence of HLA-B8 in
coeliac patients. This will be discussed in
more detail later.
Complement Changes
Reduced levels of serum complement components
C3 and C4 have been found in untreated
coeliacs compared with controls (Doe et al .
1974) and gluten challenge of treated
coeliacs has been shown to reduce serum C3
within a few hours of the challenge (Doe et
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al . 1974 ) with the appearance of complement
breakdown products (McNeish et al. 1974).
Gluten fractions have been shown to activate
the alternative pathway of complement
activation and it has been suggested that
this may be pathogenetically important
(Massey et al. 1977 ) .
Circulating Immune Complexes
Doe, Booth & Brown (1973) reported detection
of circulating antigen-antibody complexes in
60% of untreated coeliacs and 10% of treated
coeliacs using the Clq precipitation test.
Doe, Henry & Booth (1974) reported increased
immune complexes following gluten challenge.
Mohammed et al. (1976) similarly found a high
prevalence of immune complexes in coeliac
disease. Later work (Bullen et al . 1980;
Ciclitira et al. 1979), however, showed a
much lower prevalence of detectable immune
complexes which, it was felt, were unlikely
to be of pathogenetic significance. More
recently still, Hall et al. (1981), using the
sensitive Raji cell assay, detected I g A
containing complexes in 45% of coeliacs as
well as I g G or IgM complexes in 50%.
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However, the level of complexes did not
correlate with disease activity and was not
altered by gluten challenge, again suggesting
that complexes may not be a primary
phenomenon.
Altered eel 1-mediated immunity
Scott & Losowsky (1976a) reported that only
2 2% of coeliacs gave positive Mantoux tests
compared with 85% of controls, suggesting a
general defect in cell mediated immunity. In
contrast, Rossipal (1978) showed increased
skin reactivity to DNCB in coeliacs compared
with controls.
Several groups have used the response to the
plant mitogen phytohaemaggl uti ni n (which
predominantly stimulates T cells) to assess
non-specific ce11 -mediated immune
capability. The most convincing results are
again from Scott & Losowsky (1976a) who
performed dose-response curves with PHA and
demonstrated diminished transformation in
untreated coeliacs with improvement after
gluten exclusion. There was some evidence
that a suppressive serum factor was
involved. Coeliac lymphocytes have also been
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shown to transform poorly when incubated in a
mixed lymphocyte reaction with Burkitt
lymphoma cells (Maclaurin et al . 1971), a
finding thought to be relevant to the
increased incidence of malignancy in coeliac
disease.
2 . Indirect Evidence
Indirect evidence in favour of immuno¬
logical mechanisms being involved in the pathogenesis
of the mucosal lesion comes from animal models of
coeliac disease, from family studies of coeliac disease
showing an association with certain histocompatibility
antigens, from clinical studies, from the association
of coeliac disease with other "immunological" diseases
and from some observations made using the jejunal
biopsy organ culture system.
Before discussing this evidence, it is worth
considering the possible mechanisms by which abnormal
immune reactions to gluten might damage the jejunal
mucosa. These can be grouped into four main classes of
reaction (Coombs & Gell, 1975):
Type I (anaphylactic, reagin dependent). Initiated by
antigen reacting with tissue basophils and mast cells
which have been passively sensitised with antibody
(usually IgE) produced elswhere, leading to the release
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of pharmacologically active substances (vasoactive
amines). There is little to implicate this class of
reaction in the pathogenesis of coeliac disease.
Type II (cytotoxic). Initiated by antibody reacting
either with an antigenic component of the tissue or a
hapten linked to the tissue; damage to the tissue is
then mediated either by complement activation or via
lymphoid cells capable of binding to the Fc portion of
the bound antibody. These lymphoid cells are sometimes
called K (for killer) cells and the process is referred
to as antibody-dependent cellular cytotoxicity (ADCC).
Type III (damage by antigen-antibody complexes).
Initiated when antigen reacts with antibody to form
complexes which fix and activate complement. The
reaction may occur in the tissue spaces where there is
local antigen excess (Arthus reaction) or in the blood
when excess circulating antigen forms complexes with
antibody which are then deposited and activate
complement. In both situations the blood vessel walls
bear the brunt of the damage and the characteristics of
the reaction are oedema, haemorrhage and polymorph
infiltration.
Type IV (delayed hyper sensitivity, tuberculin type,
cell mediated). Initiated by interaction of antigen
with T lymphocytes specifically reactive to that
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antigen and which respond by releasing soluble
substances (lymphokines) which may be cytotoxic or
modulate the local immune response, and/or by becoming
cytotoxic. The reaction is characterised by its
delayed time course (12-48 hours after challenge) and
by infiltration of mononuclear cells, most of which are
macrophages.
In the subsequent discussion, it is necessary to
bear in mind that these are artificial distinctions and
that in vivo it is extremely unlikely that one of the
above mechanisms (with the possible exception of
IgE-mediated responses) is ever acting alone, and that
different mechanisms may predominate at different
stages in the complete time-course of a hyper¬
sensitivity reaction.
a) Animal models of coeliac disease
There are a number of naturally occurring
diseases in animals which resemble coeliac
disease to a greater or lesser extent. In
addition, various drugs and chemicals have
been shown to cause villous atrophy (see
review by Haeney, Ferguson & Asquith, 1979).
The condition from which most has been
learned is Nippostrongylus braziliensis
infestation in rats. This intestinal
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nematode causes patchy small intestinal
villous atrophy and crypt hyperplasia with
increased epithelial cell turnover (Symons,
1965), enzyme changes (Symons & Fairburn,
1963 ) and malabsorption (Symons et al .
1971). The infection is normally self-
limited and self-cure begins at around the
eleventh day. Expulsion of the worms has
been shown to require both humoral and
cellular immune responses (Dineen et al.
1973). Ferguson & Jarrett (1975), in an
elegant series of experiments, showed that
thymectomised rats infected with N.
braziliensis both failed to eliminate the
worms and largely escaped the intestinal
damage, suggesting that the villous atrophy
and crypt hyperplasia were secondary to T
eel1-mediated immune reaction to helminth
antigens. Similar conclusions have been
drawn from experiments involving allograft
rejection of small intestine (Ferguson &
Parrott, 1972, 1973; MacDonald & Ferguson,
1976). Using foetal mouse intestine (which
is sterile, thus avoiding complications in
interpretation of pathological changes)
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grafted under the renal capsule of normal
adult mice, they showed that rejection of the
graft was characterised by lymphocyte
infiltration of the lamina propria and then
of the epithelium, with villous atrophy.
Rejection in thymectomised recipients was
delayed, showing the process to be thymus
dependent (Ferguson & Parrott, 1973). The
histology thus resembled that of coeliac
disease, though the enterocytes were
unaffected until late in the rejection
process.
Graft-versus-host (GvH) disease is another
T-cell mediated condition in which the small
intestinal changes resemble those of coeliac
disease (though with less cellular
infiltration). Reilly & Kirsner (1965)
induced GvH disease in Fi hybrid mice
injected with parental spleen cells. The
mice developed severe runting with small
intestinal changes reminiscent of coeliac
disease though with pathological changes more
severe in the ileum than in the jejunum.
GvH-like reactions have been proposed as a
possible mechanism of mucosal damage in
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coeliac disease (N e i 1 d , 1981) though this
hypothesis is rather confused as no
explanation is given for how the gut lymphoid
cells to which the gluten supposedly becomes
attached are thus rendered able to recognise
other, unaltered, cells in the gut as foreign
and mount an attack on them.
Finally, Bicks and his colleagues (Bicks et
a 1 . 1967; Bicks, Azar & Rosenburg, 1967)
sensitised guinea-pigs to dinitrochloro-
benzene (DNCB) (a potent skin sensitiser,
reaction to which seems to be T cell
mediated) and then applied DNCB in an
alkaline base (Orobase) to colonic mucosa
and, by feeding, to small bowel mucosa. In
the former case, lesions reminiscent of
ulcerative colitis were produced and, in the
latter, lesions resembling those of coeliac
disease with evidence of xylose
malabsorption.
The above experiments seem to establish that
T cell mediated immune responses in the gut
are capable of causing lesions similar to
those seen in coeliac disease. They should
not, however, be interpreted as meaning that
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only T cell reactions can cause such
lesions. It is probable that the small
intestine, in common with many other organs,
has a limited number of responses to any
insult and that morphologically similar
damage can result from a wide variety of
noxious influences.
Genetic factors in coeliac disease and the
HLA system
An increased prevalence of coeliac disease in
relatives of coeliac patients has been
suspected since the 1920s. A series of
studies of first degree relatives has given a
mean frequency of coeliac disease of 13.5%
(Ellis, 1980), though in some studies
selection of relatives for jejunal biopsy was
not random. It rapidly became apparent that
the inheritance of the disease could not be
explained on the basis of a simple autosomal
recessive or sex-linked gene, though dominant
inheritance with incomplete penetrance or
polygenic inheritance remain possible
mechanisms. That genetic factors are not the
entire explanation is shown by studies of
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monozygotic twins who are discordant for the
disease (Hoffman et al . 1966 ; Walker-Smith,
1973 ) .
The most important observation in this field
has been that of the greatly increased
prevalence of the histocompatibility antigen
HLA-B8 in patients with coeliac disease
compared with controls (Stokes et al. 1972;
Falchuk et al . 1972 ; Harms et al . 1974 ).
About 80% of coeliac patients bear this
antigen compared with only around 20% of the
normal population. An even stronger
association has been reported with the D
locus antigen DW3 and the very closely
related or identical B cell alloantigen DRW3
(Keuning et al. 1976; Ek et al. 1978) as well
as with another, probably distinct, B cell
antigen (Mann et al . 1976 ). Family studies
have shown that in general within families,
coeliac disease segregates with HLA-B8
(Stokes et al . 1973 ; Harms et al . 1974 ) and
that affected members of a family usually
share HLA antigens (Falchuk et al. 1978).
Affected siblings are very rarely, if ever,
totally HLA non-identical (Falchuk et al .
1978; Ellis, 1980).
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The relevance of the above studies to the
immunological theory rests with the possible
association of genes determining the
histocompatibility antigens with genes
controlling immune responses. The HLA
complex represents the human major
histocompatibility antigen system and is the
equivalent of the H-2 complex in the mouse
(for reviews see Festenstein & Dement, 1978;
Benacerraf & Unanue, 1980). The HLA system
consists of four major genetic loci
designated HLA-A, HLA-B, HLA-C and HLA-D.
Typing for the A, B and C antigens is
performed by cytotoxicity testing using
antisera. The antigens of the D locus seem
to be analogous to the la antigens of the
mouse and are expressed only on certain
cells, notably B lymphocytes and macrophages;
D locus antigens are detected principally by
analysis of T cell reactivity in mixed
lymphocyte reactions - an in vitro model of
the recognition phase of allograft
rejection. The D related (DR) antigens are
closely linked to, and may be identical with,
the D antigens but are detected
serologically.
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The HLA loci are all located on the short arm
of chromosome 6 and are closely linked i.e.
are physically close and recombination
between loci is uncommon. Each HLA haplotype
(the specific combination of the alleles at
all loci of the histocompatibility complex)
is transmitted as a single Mendelian
co-dominant trait. In addition to close
linkage, the HLA system shows several
examples of linkage disegui1ibriurn , that is
the phenomenon of certain haplotypes
occurring more often than would be expected
from the population freguencies of the
specific alleles making up the haplotype.
In the context of coeliac disease, the known
linkage disequilibrium between HLA-A1 and
HLA-B8 has been used to explain the increased
prevalence of the former in coeliac
patients. Similarly, HLA B8 and HLA-DW3 are
in strong linkage disequilibrium in the
normal population (Keuning et al. 1975) and
it seems likely that DW3 is more closely
associated with the "coeliac disease gene"
and that B8 is merely another marker for this
gene, without being primarily involved in
pathogenesis (Strober, 1980).
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There is considerable evidence in several
species of animal that immune response (Ir)
genes which modulate the immune response to
specific antigens exist and are commonly
linked to the genes controlling the major
histocompatibility complex (Benacerraf &
McDevitt, 1972; Balner, 1976; Balcarova et
al. 1974; Landolfo et al . 1978). In man, HLA
status has been shown to affect immune
responses to several antigens, including
streptococcal antigens (Greenberg et al .
1975), influenza vaccination (Spencer et al.
1976), vaccinia virus (de Vries et al. 1977),
tetanus toxoid (Sasazuki et al . 1978 ), human
liver specific lipoprotein (Vogten et al.
1979), schistosomal worm antigens (Sasazuki,
Otta, Kaneoka et al. 1980; Sasazuki, Kaneoka,
Nishimura et al . 1980) and ragweed allergens
(Levine et al . 1972 ). Of particular interest
are the reported immunological effects
associated with possession of HLA-B8. These
include a generalised increase in immune
reactivity in the mixed lymphocyte reaction
(Osaba & Falk, 1978), increased cell mediated
immunity to liver specific lipoprotein (in
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patients with severe liver disease) (Vogten
et al. 1979) and increased antibody titres to
rubella, measles and some autoantibodies
(again in patients with chronic liver
disease) (Galbraith et al. 1976). In
addition, there is evidence of increased
immune reactivity to gluten in HLA-B8
individuals without coeliac disease, both on
the basis of increased gluten antibodies
(Scott et al . 1974) and increased lymphocyte
transformation ( Cunn i ngham-Rund1es et al.
1978). This is further discussed below.
Finally, HLA-B8 has been associated with
decreased cell mediated immunity in
scleroderma patients (Kellenburg et al . 1981)
and a functional Fc-receptor deficit on T
cells (Lawley et al. 1981).
Coeliac disease is thus associated with HLA
antigens which themselves are associated with
a variety of effects on the immune system.
It is tempting, therefore, to conclude that
these alterations in immune responses may be
implicated in the pathogenesis of coeliac
disease. Other explanations are, however,
available. Histocompatibility antigens are
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cell-surface components and the toxic
component of gluten may damage cells by
binding to these substances, the associated
immune phenomena being irrelevant.
Clinical evidence
Two clinical observations have been thought
pertinent to the immunological theory: (i)
the occurrence of "gliadin shock" - a
reaction reminiscent of an acute allergic
reaction sometimes occurrring in coeliac
children on a gluten-free diet who are
exposed to small amounts of gluten (Krainick
et al . 1958) and (ii) the improvement in the
jejunal mucosa of coeliac patients seen when
they are treated with corticosteroids without
gluten exclusion from the diet (Wall et al.
1970).
Associated diseases
There is a large number of reports of coeliac
disease occurring in association with other
diseases thought to have an immunological
basis (see Table 2) and from this it is
argued that immunological mechanisms are
likely to be important in coeliac disease
(Lancaster-Smith et al . 1974 ). Dermatitis
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herpetiformis is the condition most obviously
related to coeliac disease as it has a
similar relationship to HLA-B8 (Keuning et
al . 1976 ), the majority of the patients have
a coeliac-like lesion of the proximal small
bowel (Brow et al . 1971) and both skin and
bowel lesions seem to respond to gluten
withdrawal (Fry et al . 1973 ). The skin
contains deposits of I g A and complement at
the dermo-epithel i al junction (Seah et al .
1972) and it seems likely that these may
represent deposited immune complexes
originating from the gut (Scott & Losowsky,
1975). The association with other diseases
has also been suggested to be secondary to
circulating immune complexes (Scott &
Losowsky, 1975) though the evidence for this
is slender.
Several of the conditions listed in Table 2
are known to be more common in individuals
who have HLA-B8 (Svejgaard et al. 1975) and
the association with coeliac disease may be
secondary to the association with B8.
Overall, however, the evidence does seem in
favour of some tendency towards immunological
45
disturbance uniting these assorted diseases,
though it is worth noting that the diagnosis
of coeliac disease was not made strictly in
some earlier reports and that some of the
associations listed are only documented by
isolated case reports.
One group of diseases worthy of further
discussion is the chronic lung fibroses
associated with coeliac disease, and in
particular bird-fancier's lung. This is
because of the interesting observations from
Oxford (Hendrick et a 1 . 1978; Faux et a 1 .
1978) suggesting that coeliacs commonly have
circulating antibodies to avian antigens
without ever having kept birds and that the
antigen involved is a component of egg yolk
and is derived from the diet. This raises
the interesting possibility that these
patients have lung disease not because of
inhalation of avian antigens but because of
abnormal absorption of antigen from leaky gut
mucosa, supporting earlier theories
explaining disease associations (Scott &
Losowsky, 1975 ) .
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Also of interest is the observation that
coeliacs have a high prevalence of
autoantibodies compared with normal subjects
(Seah et al . 1971; Lancaster-Smith &
Strickland, 1971; Hodgson et al. 1976;
Williamson et al. 1976). One of these
antibodies is the well known reticulin
antibody (Seah et al . 1971; Alp & Wright,
1971; von Essen et al . 1972 ; Brown et al .
1973; Rizzetto & Doniach, 1973). This is
found in a high proportion of untreated
coeliacs and seems to decline following
gluten withdrawal (Alp & Wright, 1971; von
Essen et al. 1972) but is also found in a
quarter of Crohn's disease patients (Alp &
Wright, 1971) and in many other conditions
(Rizzetto & Doniach, 1973). Early
suggestions that the antigen involved was
cross-reactive with gluten have not been
confirmed (Brown et al . 1973 ) and it seems
probable that the antibody either reflects
non-specific tissue damage or, perhaps more
likely, a response to dietary antigens other
than gluten (von Essen et al. 1972).
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e) Organ culture studies
Both Cortisol (Katz et al . 1976 ) and the
topical steroid clobetasone butyrate (Bramble
et al. 1981) have been shown to diminish the
toxicity of gluten to coeliac biopsies in
organ culture, thus reproducing the in vivo
effect of steroids in coeliac disease
discussed above. One possible
explanation is, of course, that steroids
exert this effect through their immuno¬
suppressive actions.
3. Specific immunity to gluten
Detection of specific immunity to gluten
in coeliac disease is obviously central to the immuno¬
logical theory. There is evidence of both humoral and
cell mediated immunity to gluten. The difficulty, as
always, is deciding whether this immunity is patho-
genetically important or merely an epiphenomenon,
a) Humoral immunity
Circulating antibodies to gluten products in
coeliac disease have been known for 20 years
(Taylor et al. 1961). Taylor and his
colleagues using a tanned red cell haem-
agglutination technique, showed significantly
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higher titres of anti-gluten antibodies
(using gluten fraction III as antigen) in
both children and adults with coeliac disease
compared with normal controls. These results
have been confirmed many times using various
techniques and various fractions of gluten as
antigen (Kivel et a 1 . 1964; Alarcon-Segovia
et al . 1964; Katz et al . 1968; Kenrick A
Walker-Smith, 1970; Ferguson A Carswell,
1972 ; Kumar et al. 1976; Stern et al . 1979 a,
1979b). Stern and his colleaques, using an
immunof1uorescent technique, showed that the
bulk of their anti-gliadin antibodies were of
IgG class whilst 2 7% of coeliac children had
IgA antibody in addition (Stern et al.
1979b) .
In general, circulating antibodies to gluten
have been more easily detected in coeliacs on
a normal diet and titres are lower after a
period of gluten exclusion and do seem to
correlate reasonably with jejunal histology
(Kumar et al . 1976; Stern et al . 1979 a,
1979b). Sequential studies have been
performed on only a few patients but the
results are slightly paradoxical. Rossi pal
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(1974) showed that in three coeliac children
antigluten antibody titres rose in the first
few months of a gluten free diet. Scott
(1975) found a similar pattern in four of
eight adult coeliacs and Stern et al . ( 1979 a)
similar results in three of four children
tested in the first three months of gluten
exclusion. Stern et al. also reported
paradoxical decreases in titres after gluten
challenge. These results have been
interpreted as supporting a pathogenetic role
for gluten antibody as it is argued that
antibody in the gut which normally complexes
with gluten antigen to cause damage is free
to diffuse into the circulation when antigen
load is reduced (Scott, 1975).
There has, however, been doubt as to the
importance of gluten antibodies in patho¬
genesis since the early reports of their
existence. Firstly, coeliac patients also
have abnormally high titres of circulating
antibodies to dietary antigens other than
gluten. These include milk antigens, egg
antigens, antigens from cereals other than
wheat and sera from a variety of animal
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sources (Taylor et al . 1964; Kivel et al .
1964; Ferguson & Carswell, 1972; Stern et
al. 1979b). Some of the gluten antibodies
are to components of gluten known to be
harmless (Stern et al . 1979b). Secondly,
antibodies to gluten are found in other
gastrointestinal diseases such as aphthous
ulceration, pernicious anaemia, duodenal
ulceration, ulcerative colitis (Taylor et
al . 1964 ) and in a variety of mal absorpti ve
disorders in children (Stern et al. 1979a),
as well as in a few normal controls (Taylor
et al . 1964 ). Though data are very scanty,
it seems that titres of antibodies to dietary
antigens other than gluten fall after gluten
exclusion without an initial rise (Scott,
1975; Kumar et al. 1976).
Antibodies to gluten have also been found in
the intestinal secretions of coeliacs but are
similarly non-specific both with regard to
antigen and disease (Ferguson & Carswell,
1972 ) .
Results of studies on anti-gluten antibody
production by cultured jejunal mucosa are
conflicting. Falchuk & Strober (1974) showed
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that coeliac mucosa challenged in vitro with
gluten responded with a marked increase in
synthesis of IgA and IgM antibodies and that
half of the synthesised antibody had anti-
gliadin specificity. Brandzaeg & Baklien
( 1976 ), however, using immunohistochemical
techniques, found that only 5.7% of IgG cells
and 1.6% of IgA cells in a biopsy from an
untreated coeliac were producing antibodies
to gluten, whilst no antibody to gluten was
detected in several other untreated coeliac
biopsies.
The relation of anti-gluten antibodies to
HLA-B8 status has been investigated by Scott
et al . ( 1974 ). These workers found that
coeliac patients, whether B8 or not, tended
to have high titres of gluten antibodies.
However, in a group of non-coeliac controls,
including patients with chronic liver disease
who had high titres of antigluten antibody,
the antibody titre was clearly affected by
HLA-B8, being higher in the group having the
B8 antigen. It was suggested that this may
reflect a specific immune response gene for
gluten in linkage disequilibrium with
HLA-B8. It is of interest that humoral
responses to gliadin in the mouse have also
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been shown to be linked with the major
histocompatibility complex (Johnson et al .
1980) .
Though the importance of humoral immunity to
gluten has been questioned on the grounds
outlined above, support for its possible
importance has come from clinical studies
involving (i) skin tests with gluten
subtractions (ii) the site, timing and nature
of the intestinal lesion seen after gluten
challenge and (iii) some in vitro studies.
(i) Skin testing with gluten
Early results of skin tests with
relatively crude gluten preparations
gave generally negative results
(Collins-Williams & Ebbs, 1954; Alvey
et al . 1957 ; Breton et al. 1959 ;
Housley et al. 1969). Asquith (1974)
showed histological changes of a
mononuclear cell infiltrate after skin
testing with gluten fraction III, but
these occurred equally in coeliacs and
controls and so cannot be considered
relevant. Baker & Read (1976), using
a crude peptic-tryptic digest of
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gluten found positive skin reactions
in 50% of untreated coeliacs and about
20% of treated coeliacs with no false
positives in normal controls. This
reaction was maximal at 5-8 hours, was
correlated with the presence of serum
gluten antibodies and histologically
consisted of an infiltrate of poly¬
morphs and mononuclear cells - all
features of an Arthus (type III)
reaction. Anand et a 1 . (1977)
reported a similar time course for
skin reactions to fraction B2 and to
gluten fraction III, with 100% of
coeliacs responding to B2. There has
been no real evidence of either
immediate (type I) or delayed (type
IV) hypersensitivity to gluten in any
study.
(ii) Site and timing of mucosal damage
after gluten challenge
Studies on this problem have produced
differing results. Dissanayake et
al. (1974) found epithelial cell
damage preceding changes in the
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basement membrane and capillaries,
whilst Shiner (1973) found the
earliest changes in the subepithelial
tissues. In general, changes have
been found within a few hours of
challenge. Anand et al. (1981) not
only confirmed that the timing of the
damage was consistent with an Arthus
reaction but that the histology was
also compatible, though immuno¬
fluorescence for complement deposition
was negative. This last finding
disagrees with earlier studies where
there was evidence of immune complex
and complement deposition in the
mucosa (Shiner & Ballard, 1972; Doe et
al. 1974).
( i i i) In vitro studies
In contrast to the above work which
is, overall, in favour of a type III
reaction to gluten, Ezeoke and his
colleagues (Ezeoke et al. 1974) have
shown evidence of a type II reaction
to gluten by demonstrating that
coeliac sera commonly contain anti-
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bodies capable of co-opting K cells to
attack various gluten-labelled
targets, including normal human
jejunum. Although these studies can
be criticised on the basis of crude
methods of organ culture and possible
irrelevance of the other targets
chosen (chicken red cells and
cellulose particles), the results are
convincing.
Cellular immunity
In vitro measurement of cell mediated
immunity is a difficult subject. There are
essentially three types of assay of which two
have been used in the context of coeliac
disease.
(i) Cytolytic T cell assays Assays for
cytolytic action of T cells provide
perhaps the most direct and
understandable assessment of cell
mediated immunity. They are generally
performed by labelling target cells
with 51Cr and measuring cytolysis by
isotope release on exposure of the
target to T cells. The assay is only
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applicable when cell-surface antigens
are involved and has not been used in
coeliac disease.
( i i) Lymphocyte transformation assays
Lymphocytes exposed to antigen to
which they are sensitised react by
blast transformation which can be
measured in a variety of ways, but is
now most often done by measuring the
incorporation of labelled thymidine
into DNA produced by the transformed
cells. The responding cells probably
belong to a number to T cell sub-
populations and may also include B
eel Is.
This assay has been extensively used
in coeliac disease, but with somewhat
conflicting results (see review by
Asguith & Haeney, 1979). Early
studies failed to show transformation
of peripheral blood lymphocytes of
coeliacs in response to gluten
(Housley et al . 1969 ; Ansaldi et al .
1970; Morganroth et al . 1972 ) though
mesenteric node lymphocytes did
respond (Housley et al. 1969).
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Other work, however, has suggested
that peripheral blood lymphocytes may
show a (usually slight) reaction to
gluten fractions in a proportion of
coeliacs (Asquith, Housley & Cooke,
1970; von Bullow et al . 1974; Scott,
1975; Holmes et al. 1976; Sikora et
al. 1976). This proportion is greater
in coeliacs on a gluten free diet than
in those on a normal diet and it has
been suggested that this represents
trapping of g 1 uten-react i ve
lymphocytes in the gut by gluten
antigen in a normal diet. Once gluten
is excluded these cells are free to
join the recirculating pool (Holmes et
al . 1976 ) .
These studies are attractive but are
open to criticism. The amounts of
antigen used have been very large (up
to 4mg/ml), and the changes seen
slight. Expression of results has
generally been as transformation
ratios which may be misleading (Haeney
& Asquith, 1976). In at least one
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study (Sikora et al . 1976 ), which
claimed to show significant
transformation to fraction B2 in a
high proportion of coeliacs, peak
responses were seen at 48 hours - a
time course much more in favour of
non-specific lymphocyte stimulation
(as by lectins) than a specific
antigen-induced reaction, where
maximal response is generally seen at
five to seven days (Valentine, 1971;
Waithe & Hirschhorn, 1973).
By analogy with the humoral responses
to gluten, it is clear that it is
necessary to show cell mediated
reactions to gluten in coeliac disease
are specific to gluten by testing
other dietary antigens. This has not
been adequately done, though Asquith
et al. (1970) reported essentially
negative results with egg albumin and
casein in a small group of patients.
However, Jos ( 1974 ) has found
transformation with milk protein in
some coeliac children without overt
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milk sensitivity, though no
experimental details were given.
Finally, there is a single report of
increased lymphocyte transformation in
three of 15 coeliacs with an antigen
consisting of a crude freeze-dried
extract of normal human jejunal mucosa
(Scott & Losowsky, 1976b). The
significance of this is not clear, but
two of the three responders were
suffering from the relatively rare
complication of small bowel
ulceration, and the response may have
particular relevance to this
complication.
( i i i) Lymphokine assays
One of the features of cell mediated
immune reactions is the liberation of
soluble mediators by T lymphocytes
when they are exposed to an antigen to
which they are specifically reactive.
These mediators are known as
lymphokines (Dumonde et al. 1969).
Measurement of lymphokine activity has
thus been used as a measure of the
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degree of cell mediated immunity to
various antigens.
Lymphokines are identified by their
biological activity and have not been
fully characterised. Biological
activities of lymphokines include
migration inhibition factors for both
macrophages and leucocytes, skin-
reactive factor, transfer factor,





"stickiness" and interferon (Sell,
1980). Of these, the factors
affecting leucocyte adherence and
migration inhibition have been studied
in coeliac disease.
(a) Leucocyte adherence inhibition
Two groups have reported a decrease in
leucocyte adherence when mixed
leucocytes from coeliac patients were
exposed to gluten fractions (Allardyce
& Shearman, 1975; Stosiek & Varga,
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1980). Allardyce & Shearman did
comment, however, that the T cell
mediation of this test was not
established and that, using PPD, they
had evidence that other factors were
involved. It is fair to comment that
this test is difficult to quantitate
and that aberrant results and the
involvement of serum factors have been
reported, even using antigens such as
PPD (Bullen & Losowsky, 1978a).
(b) Migration inhibition tests There
are two ways in which miqration
inhibition tests can be performed. In
the indirect assay lymphocytes are
cultured with the antigen and the
migration inhibitory activity of
cell-free supernate is then assessed
on whatever target cell is chosen
(guinea-pig peritoneal macrophages or
normal human leucocytes being the
commonest). In the direct assay,
mixed blood leucocytes are cultured in
the presence and absence of antigen
and their migration is compared.
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Inhibition of migration in the
presence of antigen is a positive
response. Migration is measured as
the area over which cells spread
having either been packed into
capillary tubes or incorporated into
sloppy agar droplets. Results of
these last two techniques correlate
closely (Adelman et al . 1980). An
example of the capillary tube method,
with gluten fraction III as antigen,
is shown in Figure 1.
The first results using the Leucocyte
Migration Inhibition (LMI) test in
coeliac disease came from Ferguson et
al . ( 1975 ). These workers used a
variation of the indirect test by
incubating fragments of jejunal
mucosal biopsies with or without the
addition of cx-gliadin. Culture medium
from biopsies from coeliac patients
cultured with a-gliadin was shown to
inhibit the migration of blood
leucocytes from healthy controls.
These results have been confirmed by
Leucocytesmigrating outfromtube Wellcontaining controlulture medium
Leucocytemigrationinhibited
inthepres nceofgluten




FIG.1.ThecapillarytubdirectLe cocytMig ationInhibitiont st
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Howdle et al . ( 1979 ) who also observed
that the inhibition was greater with
medium from biopsies of untreated
coeliacs than from coeliacs treated
with a gluten-free diet.
Douwes (1976) reported use of the
direct LMI test with peripheral blood
leucocytes in coeliac disease. Using
an unspecified gluten subtraction, he
demonstrated leucocyte migration
inhibition in 100% of his coeliac
patients and in none of his controls,
either healthy or suffering from
other gastrointestinal disease. The
patients' dietary status was not
given.
Bullen & Losowsky (1978b) reported
less dramatic results with gluten
fraction III. As a group, untreated
coeliacs showed significant inhibition
of leucocyte migration with gluten,
but only 13% gave results outside the
normal range. Patients on a gluten
free diet, however, showed more marked
inhibition with 54% outside the normal
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range, i.e. showing definite
sensitisation. In treated patients,
patients with raised interepithelial
lymphocyte counts in the jejunal
mucosa showed more migration
inhibition. These results were felt
to support the suggestion of Holmes et
a 1 . (1976) relating to sequestration
of gluten-reactive lymphocytes in the
gut by dietary gluten.
Askenazi et al . ( 1978) suggested that
the LMI test could be used
diagnostically. Using their own B2
and B3 subtractions at a very low
concentration (conventionally high
antigen concentrations are used in the
direct LMI test) they found that 96%
of their coeliac patients gave a
positive response to one or other
antigen compared with only 6% of
controls. Controls were said to react
only to B2 or B3, never to both, and
reactivity of coeliac leucocytes was
unaffected by dietary status. This
study is open to criticism, however,
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as the results were expressed as
percentaqe migration inhibition rather
than as a migration index (the ratio
of areas of migration in the presence
and absence of antigen). Controls in
whom the migration index was greater
than one (i.e. those whose leucocytes
migrated more in the presence of
gluten than in control medium) were
shown as having 0% migration
inhibition. Parametric statistics
were then used to calculate a normal
range when the results from the
control group were clearly
non-Gaussian in distribution. Despite
this, however, separation between the
groups was impressive.
Haeney & Asquith (1978), using
a-gliadin, reported results very much
like those of Bullen & Losowsky
(1978b) and also used a-1actalbumin as
a control dietary antigen with
negative results. They also found
that treated coeliacs gave more
positive results with the gluten
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antigen than did untreated coeliacs.
Ashkenazi et al. (1980) attempted to
explain the discrepancy between their
results and those of other workers.
Using gluten fraction III in their
system, they obtained results
reasonably comparable with other
reported results but still much less
impressive than their B2 or B3
results. They also found that mixing
B2 and B3 decreased responses and
suggested some form of masking of
antigenic sites on the molecules when
mixed, though a mechanism for this is
a little difficult to envisage. The
same group (Ashkenazi et al. 1981)
have recently revised their previous
opinion and agreed that gluten
exclusion seem to increase migration
inhibition by gluten of peripheral
blood leucocytes.
Finally, O'Farrelly et al. (1981) have
used the indirect LMI test on
peripheral blood leucocytes and find
that 100% of untreated and 93% of
treated coeliacs give positive results
with very small amounts of a-gliadin.
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Problems relating to the LMI test and cellular
immunity to gluten
There are several aspects of the use of the
LMI test and the role of cell-mediated immunity in
coeliac disease which remain controversial. First,
there is the disagreement as to the diagnostic power of
the direct LMI test (there is as yet insufficient data
on the indirect test to assess its value). One
possible explanation is that proposed by Ashkenazy,
which is that their B2 subtraction is much superior to
cruder gluten preparations and this gives better
results at much lower antigen concentrations. However,
B2 and the cruder fractions have only been directly
compared by Ashkenazy et al. in their agar drop system
(Ashkenazy et al. 1980) and then only with
concentrations of gluten fraction III known to be
sub-optimal in the capillary tube system (Bullen &
Losowsky, 1978 ) .
Second, the consensus now is that cellular
sensitivity to gluten, whether detected by the LMI test
or by transformation studies, is more easily detected
in the blood of patients on a gluten-free diet and in
biopsies of patients on a normal diet. This is
explained by the shift of committed lymphocytes
proposed by Holmes et al . ( 1976 ). However,
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simultaneous studies of reactivity of blood cells and
biopsies have not been performed and the effects of
gluten exclusion for varying lengths of time have not
been formally studied. Related to this problem is that
of the relative insensitivity of biopsies from treated
coeliac patients to the toxic effect of gluten in vitro
and the resensitisation conferred by co-culture of such
biopsies with "untreated" biopsies (Falchuk, Gebhard &
Strober, 1974). This seems to tie in nicely with the
concept that treated biopsies have insufficient
effector lymphoid cells left in them to render them
sensitive to gluten (assuming that the lymphoid cells
or their products are causing the mucosal damage). The
hypothesis has not, however, been tested by co-culture
of the biopsies with peripheral blood lymphoid cells
which, in treated coeliacs, is where the evidence
suggests the g 1 uten-reactive cells are to be found.
Third, all studies of cell-mediated immunity to
gluten have compared coeliacs with controls without
regard for HLA status. About 80% of coeliacs have
HLA-B8 compared with about 20% of unselected controls
(Falchuk et al . 1972 ). However, HLA-B8 has been
associated with a generalised increase in immune
responsiveness (Vladutiu & Rose, 1974) and increased
humoral responses to gluten (Scott et al . 1974). More
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recently, Cunningham-Randies et al . (1978) have shown
increased lymphocyte transformation with gluten in
normal individuals having HLA-B8. It thus seems
pertinent to study the influence of HLA-B8 on the
immune response to gluten as measured by the LMI test.
Fourth, the importance of humoral immunity to
gluten in pathogenesis has been questioned partly
because of the occurrence of other dietary antibodies
in coeliac disease. Tests of cell mediated immunity to
dietary antigens have not been widely performed, and so
far as the LMI test is concerned the only antigen
tested has been a-1 actalbumin (Haeney & Asquith,
1978). The specificity of the response to gluten
cannot thus be properly assessed.
Finally, there is the problem of the
interpretation of LMI test results. The justification
for in vitro tests of cell mediated immunity
essentially lies with the correlation between the
results of the test and in vivo evidence of cell
mediated immunity, usually a skin test. In coeliac
disease skin tests have not supported the concept of
cell mediated immunity to gluten and there are many
alternative mechanisms by which inhibition of leucocyte
migration may occur other than by T-lymphocyte produced
lymphokine. These include migration inhibitors
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produced by B cells (Rocklin et al. 1974) or other cell
types (Tubergen et al. 1972), cytophilic antibody
(Heise et al. 1968; Kostiala & Kosunen, 1972; Lockshin
et al . 1973 ; Amos et al . 1967 ; Wasserman & Packalen,
1965; Ortiz-Ortiz et al. 1974), immune complexes
(Spitler et al. 1967; Kotkes & Pick, 1975) and direct
toxicity of antigen (Main i et al. 1973 ). Further
investigation of the mechanism and cellular basis of
the L MI test in coeliac disease is needed to justify
the general assumption that it is a measure of T-cell
reactivity to gluten.
III. The lectin theory
The third and most recently proposed possible
mechanism for gluten toxicity is the lectin theory of
Weiser & Douglas (1976). Essentially, Weiser & Douglas
propose that in coeliac disease there is some
abnormality of the enterocyte cell membrane which
allows gluten to bind to the cells in a lectin-like
manner, and that this binding is toxic to the cells.
The proposed membrane abnormality is a change in the
carbohydrate component of the surface membrane
glycoproteins. In order to assess this theory, it is
necessary to discuss some of the properties of lectins
and the structure, metabolism and function of cell
surface glycoproteins.
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Lectins Lectins are naturally occurring proteins
which have the ability to agglutinate cell suspensions
(for review see Sharon & Lis, 1972). They are
particularly common in plant seeds, especially legumes,
but are also found in some invertebrate and lower
vertebrate animals. Lectins have been used in some
classical experimental work in medicine. For example,
Ehrlich used the lectins ricin and abrin in the 1890s
in an early demonstration of immunological
specificity. In the early years of this century
Landsteiner began work on the agglutination of red
blood cells by lectins which has led to a much fuller
understanding of human blood group systems. The
observation by Nowell in 1960 that certain plant
lectins stimulated lymphocytes to transform has led to
an enormous amount of work on lymphocytes, their sub¬
classes and their role in cellular immunity, and to the
study of human chromosomes in vitro. Currently the
observation that some lectins differentia 11y
agglutinate normal cells and cells transformed by
oncogenic viruses or carcinogens has led to much work
on the surface properties of malignant cells.
The mechanism of interaction between lectins and
cell membranes involves specific binding of cell-
surface carbohydrates and can be inhibited by simple
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sugars. Most lectins interact with only a single sugar
but in some the specificity is broader and includes
closely related sugars (Weir, 1980). The specificity
of this reaction has been compared with that of the
antigen-antibody reaction.
Cell-surface carbohydrates There is considerable
evidence that cell surfaces are characteristically
covered in a complex array of carbohydrate moieties,
often associated with proteins or lipids. Blood group
and histo- compatibility antigens are two obvious
examples. The biosynthesis of cell-surface glyco¬
proteins depends on enzymes known as glycosyl-
transferases and is not directly dependent on RNA.
Each glycosyltransferase catalyses the reaction:
Sugar-nucl eoti de + o 1 i gosacchar i de-acceptor^-
sugar-oligosaccharide-acceptor + nucleotide.
Elongation of the oligosaccharide chains is effected by
the addition of monosaccharide units through the action
of different glycosyltransferases in a specific
sequence. The product of each reaction serves as the
specific substrate for the next enzyme in the
sequence. The sequence of reactions does not, however,
always proceed to completion, leading to micro-
heterogenei ty of surface gl ycoproteins (Roseman, 1970 ).
7 3
The functions of cell surface carbohydrates are
not entirely understood, but it seems likely that they
are intimately involved in cellular recognition and
intercellular adhesion (Roseman, 1970; Roth et al.
1971; Roth & White, 1972; Roth, 1973). As
informational molecules carbohydrates have certain
advantages over proteins or nucleic acids due to their
ability to exist in a number of spatial configurations,
to be linked in a number of different ways and their
ability to form branched structures. It has been
calculated, for example, that a twelve residue
oligosaccharide of three mannose, three N-acetyl-
glucosamine, three galactose and three sialic acid
residues has 10 24 possible structures (Weir, 1980).
There is good evidence that carbohyd rates are important
in cellular recognition in primitive creatures such as
the slime mold (Weir, 1980) and there is also evidence
in mammals from experiments with embryo neural retina
cells (Roth et al . 1971) and platelets (Chesney et al.
1972). The binding of bacteria to macrophages also
seems to be mediated via a lectin-like attachment (Weir
& Ogmundsdottir, 1977). Interestingly in this last
case the lectin-like molecule seems to form part of the
ph agocyte cell wall.
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The theory itself Weiser & Douglas (1976) point out
that the number of incomplete carbohydrate chains is
increased in viraliy transformed cells, intestinal
tumour cells and normal intestinal crypt cells (Burger,
1973; Podolsky & Weiser, 1973). Immature intestinal
epithelial cells exhibit different lectin-binding
patterns to mature enterocytes and have altered
glycosyltransferase activities and endogenous acceptors
(Etzler & Branstrator, 1974; Weiser, 1973a, 1973b).
Transformed intestinal cells are more susceptible to
lectin-induced cytotoxicity in vitro than normal cells
(Shoham et al . 1970 ). It is suggested that in coeliac
disease a defect in eel1-membrane carbohydrates allows
gluten (or a fraction thereof) to bind in a lectin-like
manner to the incomplete carbohydrate and that this
binding is toxic to the cell. Transient gluten
intolerance is explained by the appearance on the
villus of immature epithelial cells as the epithelium
attempts to repair itself after an insult such as viral
enteritis.
The theory is an attractive one, especially considering
the evidence for carbohydrate involvement in
intercellular adhesion as one can easily envisage a
lectin interfering with this process so that cells are
more easily shed. Increased enterocyte shedding is a
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feature of untreated coeliac disease (Croft et al .
1968). However, the evidence above is all
circumstantial, and direct experimental evidence is
scanty.
Experimental evidence relating to the lectin
theory
The most basic piece of evidence to support the lectin
theory would be the demonstration that toxic gluten
peptides bind to coeliac jejunal mucosa but not to
normal mucosa. Perhaps surprisingly there is little
evidence that this is so. Rubin et al. (1965) used an
immunofluorescent technigue and showed binding of
gliadin to the jejunal mucosa of nine adult coeliacs.
Binding seemed maximal in the crypt cells and
fluorescence was mainly cytoplasmic. Only one of five
controls showed any positive fluorescence. This work,
however, has never satisfactorily been repeated. Hobbs
(1974) comments that his preparation of rhodamine-
labelled gliadin tended to "stick to everything" and
could not be used for localisation studies. In fact,
the only other positive report in this area comes from
Douglas himself (Douglas, 1976). He prepared a glyco¬
protein extract of gluten (termed glyc-gli) by acetic
acid-ethanol extraction followed by trichloroacetic
1 o c
acid precipitation and labelled this with I. The
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glyc-gli was shown to be toxic in vivo. When incubated
with intestinal homogenates binding could be shown to
mucosa from treated and untreated coeliacs, but only
minimally to mucosa from controls. Iodinated a-qliadin
did not bind to any specimens. The binding of glyc-gli
was reduced by 40% by incorporation of five millimolar
rham nose and 30% by arabinose, suggesting a sugar
specificity. Oddly, galactosamine increased binding to
coeliac mucosa by 46%. With normal mucosa binding was
increased by gal actosamine and arabinose but unaffected
by rhamnose, which thus seemed to be the sugar
specificity of the putative lectin.
Weiser & Douglas (1978) have also studied the qlyco-
syltransferase activities of isolated enterocytes in
coeliac disease. They found an increased activity of
galactosyltransferase in coeliacs compared with
controls with both endogenous and exogenous acceptors.
With endogenous acceptors (those naturally occurring on
the cell surface) the kinetics of the reaction with
this enzyme were also altered, suggesting an increase
in the number of endogenous acceptor sites. Results
did not correlate with histological appearance or time
on a gluten free diet, suggesting that the changes were
not merely secondary to mucosal damage and the presence
of immature cells on the villi. However, the methods
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used are open to criticism as they are technically very
difficult, were performed on relatively few patients
and, for technical reasons, factors such as cell
"leakiness" and cell surface hydrolytic enzymes were
not evaluated.
Machell (1979) has studied the binding of a range of
fluorescein-labelled lectins of known sugar
specificities to enterocytes from coeliac patients and
normals, using the lectins as probes to identify
carbohydrate moieties on the cell membranes. He found
no differences between coeliac and control biopsies.
Finally, it is worth noting that the previously
discussed work of the Galway group (Stevens et al .
1978) concerning the role of carbohydrate in gluten
toxicity may be relevant to the lectin theory.
One problem with the lectin theory is the scarcity, and
technical difficulty, of experimental test systems.
One possibility which has not been explored is assay of
cell membrane inositol phospholipid turnover, as there
are some grounds for believing that this may be
affected by lectin binding to cell membranes.
Phosphatidylinositol turnover in cell membranes
Myoinositol was originally described as an essential
growth factor early this century, yet its function
remained unclear until recently when it was discovered
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that most of the inositol in eukaryote cells exists in
combined form in the phospholipid of cell membranes.
The metabolism of these inositol phospholipids is now
well worked out (see review by Michell, 1975). The
metabolism is in the form of a cycle (shown in Fig.2).
Phosphatidyl inositol is synthesised from 1,2, diacyl-
glycerol via phosphatidic acid. In response to various
stimuli it is broken down to release the 1,2, diacyl-
glycerol backbone which is then reutilised in the re-
synthesis of phosphatidyl inositol. The rate of
degradation of the phosphotidylinositol (hereafter
referred to as the PI turnover) can thus be measured in
two ways: (1) by measuring the incorporation of
labelled inorganic phosphate into phosphatidyl inositol
(which necessitates separation of the cell membrane
lipids as phosphate is also incorporated into other
phospholipids) or (2) by use of labelled inositol which
is specifically incorporated into phosphatidyl inositol.
The importance of the PI turnover cycle lies in its
relation to the interaction of cell membranes with a
variety of stimuli. Increased PI turnover has been
described in a wide variety of tissues in response to a
wide variety of stimuli (see Table 3). It is note¬
worthy that the stimuli share the common feature that













FIG. 2. The phosphatidylinositol turnover cycle
TABLE 3
Stimuli reported to increase phosphotidylinositol
turnover and the tissues affected
Stimulus








C a e r u1 in
Thyroid-stimulating hormone
Long-acting thyroid stimulator


















































Collagen PI ate 1ets
Phytohaemagglutinin Lymphocytes (T?)
Lens culinaris lectin Lymphocytes (T?)
Concanavalin A Lymphocytes (T?)
Soya bean lectin Lymphocytes (T?)
Wistaria floribunda lectin Lymphocytes (T?)
Anti1ymphocyte antiserum Lymphocytes (B & T?)
Anti-immunoglobulin antiserum Lymphocytes (B?)








































(from Michel 1 , 1975 )
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surface receptors. It is also noteworthy that the
stimuli include several lectins. Studies involving
lectins date back to 1968 when Fisher & Mueller
reported increased PI turnover in lymphocytes in
response to phytohaemagg1utinin . Later work (Mario et
al. 1975) showed that other lectins had the same effect
but only if they stimulated lymphocyte transformation.
Non-mitogenic lymphocytes had no effect.
What relevance does this have to coeliac disease? If,
as is postulated by Weiser & Douglas, gluten affects
coeliac enterocytes by a lectin-like binding to the
cell membrane, then it is at least possible that a
marker for this reaction may be an increase in PI
turnover in these cells. With the advent of jejunal
mucosal biopsy organ culture it is now technically
feasible to study phospholipid turnover in jejunal
mucosa and the system has been used to study lipo¬
protein synthesis and secretion (Rachmilewitz et al.
1980), but PI turnover and the effects of gluten have
not been studied .
The lectin theory and the LMI test
One final point to consider is the possibility that
some of the experimental results discussed as relevant
to the immunological theory may be explained by the
lectin theory.
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Many lectins are mitogenic for lymphocytes and,
consequent on this non-specific activation, cause the
release of lymphokines. The lectin from the asparagus
pea has also been shown to elicit a direct chemotactic
effect from human polymorphs (Van Epps & Tung, 1977).
It is thus possible that some of the results of
transformation assays and the LMI test may be explained
by a lectin effect of gluten rather than in terms of an
immune response to gluten. If this were so the effects
could be blocked by the sugar specific for the lectin -
in the case of gluten Douglas' results (Douqlas, 1976)
suggest that this is rh am nose. This possibility has
not been experimentally explored.
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AIMS OF THE STUDY
1) To further evaluate the direct Leucocyte Migration
Inhibition test in coeliac disease with particular
reference to:
(a) the influence of histocompatibility
type on results of the test in normal
controls and in coeliac patients
(b) the effect of dietary status on
results
(c) the specificity of the test with
respect to the antigen used; in
particular, to determine whether
positive results are obtained in
coeliac disease with dietary antigens
other than gluten
(d) the relationship between production of
inhibitory factors by jejunal mucosa
and by peripheral blood leucocytes
(e) a com pari son of two subtractions of
gluten as antigen
(f) assessment of whether gluten may be
affecting results by means of a direct
lectin-like binding to leucocytes
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(g) an investigation into the mechanism by
which gluten causes migration
inhibition and into the assumption
that it does so by inducing lymphokine
production by specifically sensitised
T lymphocytes
To extend the use of jejunal mucosal biopsy organ
culture techniques in investigating pathogenesis:
(a) by co-culturing biopsies from treated
coeliacs with their own peripheral
blood lymphocytes in an attempt to
restore gluten sensitivity to these
biopsies
(b) by using the technique to measure
phospholipid turnover in the jejunal
mucosa as a possible index of a
lectin-like action of gluten
MATERIALS & METHODS
"Let us work without theorizing 'tis the only way





As discussed in the Introduction, ail coeliac
patients participating in these studies fulfilled one
of the following criteria for the diagnosis of coeliac
disease:
1) a jejunal biopsy taken whilst the patient was
on a normal diet which showed typical changes
of coeliac disease, with a second biopsy
taken after a period of gluten exclusion
which showed unequivocal histological
improvement or:
2) an initial biopsy taken whilst the patient
was on a gluten-free diet with a second
biopsy taken after a gluten challenge with
clear histological deterioration in the
second biopsy compared with the first.
A total of 58 patients was studied. Twenty eight
were male and 30 female. Mean age was 36.8 years
(range 11 - 68 years).
Normal controls. A total of 31 normal healthy
controls, drawn from hospital personnel was studied.
There were 16 males and 15 females. Mean age was 33.5
years (range 20 - 54 years).
Biopsied controls. A group of 20 patients undergoing
routine jejunal biopsy for the exclusion of coeliac
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disease was also studied. These comprised eight men
and 12 women, mean age 29.7 years (range 16 - 56
years). Jejunal biopsies showed no evidence of coeliac
disease in any case. Final diagnoses were as follows:
Irritable Bowel Syndrome - 6
Crohn's disease - 3
Family history of coeliac
disease - 3
Anaemia ? cause - 3
Chronic pancreatitis - 1
Anorexia nervosa - 1
Aphthous ulceration - 1
Abdominal lymphoma - 1
Foodallergy - 1
Details of the patients and controls used in each
experiment are given in the appropriate section.
The Leucocyte Migration Inhibition Test
General technique. The LMI test was performed
routinely using a capillary tube method as described by
Bullen & Losowsky (1978). 20ml of venous blood was
withdrawn under sterile conditions and defibrinated by
repeated inversion in a 30ml sterile plastic Universal
container (Sterilin, L.I.P. Ltd., Shipley) containing
8-10 sterile glass beads. The fluid defibrinated blood
was then decanted into another Universal container and
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mixed with 10ml of Dextran 150 in saline (Dextraven
150, Fisons Ltd.). This was then allowed to sediment
for 30 minutes at room temperature and the leucocyte-
rich supernate aspirated using a sterile 10ml syringe.
This cell suspension was then centrifuged at 200 x g
for 10 minutes to pellet the cells and the supernate
discarded. The cells were then washed twice in medium
and finally adjusted to give a packed cell volume of
about 50%. This gave a leucocyte concentration of
about 10 ' cells/ml. The medium used was Medium 199
(Wellcome Reagents) containing 10% foetal calf serum
(FCS) (Wellcome Reagents), 1000 units/ml each of
penicillin and streptomycin (prepared by the Pharmacy,
St. James's University Hospital, Leeds) and adjusted to
pH 7.4 with 8.4% sodium bicarbonate (Pharmacy Dept.,
St. James's University Hospital).
The cell suspension was then drawn up into 10 y 1
micro-capillary tubes. These were Drummond Microcaps
(20ul) (L.I.P. Ltd.) which had been scored with a
diamond and broken into halves, then resterilised with
dry heat (160UC for one hour). The cell suspension was
then drawn up to leave a slight gap at one end of the
tube and this end was heat sealed in a butane gas
flame. Care was taken not to char the cells. The
filled capillaries were transferred to another sterile
Universal and the cells gently packed by centrifugation
at 50 x g for three minutes. The tubes were then
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scored with a diamond and broken at or just below the
cell-fluid interface before being placed in the
Leucocyte Migration plates. Tubes showing evidence of
cell charring, haemolysis or fragmentation of the cell
column were discarded. The Leucocyte Migration plates
(Sterilin Ltd.) had the rims of their wells coated with
sterile silicone grease. The sealed end of the
capillary tube was also dipped into silicone grease to
fix its position in the well. The wells were then
filled with the appropriate medium and sealed with
Chance Propper cover slips (22x22 mm, No 1%; L.I.P.
Ltd.) taking care to exclude air bubbles and the plates
incubated at 37°C. The total time between filling of
the capillary tubes to placing the plate in the
incubator was never more than 30 minutes, and the cut
ends of the filled capillaries were never exposed to
the air for more than 30 seconds. These details are
critical and have been shown to affect the result of
the test (Maini et al . 1973 ). All manipulations were
performed in a Pathfinder sterile cabinet (Pathfinder,
Havant, Hants.).
All cultures were performed in quadruplicate.
After incubation at 37UC (standard incubation time was
20 hours - see below) the plates were read by
projection of the fans of migrating cells at constant
magnification using an overhead projector. The
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projected images were traced onto paper and their areas
measured with a fixed arm planimeter (Shandon
Scientific Co. Ltd.). Any wells showing evidence of
infection (this occurred on only one occasion), pH
change or air bubbles were discarded.
Results are expressed as a Migration Index which
is calculated as :
Migration
Ind ex =
Mean area of migration in the presence of antigen
Mean area of migration in control medium
Thus a lower Migration Index indicates increased
i mmunity.
Antigens
G1uten fraction III was made from BDH wheat gluten
by the method of Frazer et al . ( 1959) and was freeze-
dr i ed.
Gluten subfraction B2. lOmg of B2 was kindly
supplied by Dr. Azaria Ashkenazi, Kaplan Hospital,
Rehovot, Israel.
Purified Protein Derivative (PPD). Lyophilized
preservative-free PPD was obtained from the Ministry of
Agriculture, Fisheries and Food, Weybridge.
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Diet ary antigens. The dietary antigens studied
were prepared as described below. Relatively crude
antigens were used deliberately, for two reasons: (1)
similar crude preparations have been used in most
reported antibody studies in coeliac disease and (2) it
seemed more likely that crude extracts of foods would
contain antigens actually found in the diet than would
the highly purified food extracts which are
commercially available.
Egg. 15g of hard-boiled egg white was
homogenised in 15ml of 0.9% saline, filtered and
sterilised by autoclaving. This stock solution was
then diluted in medium to the appropriate
concentration. The protein content of the stock
solution (estimated by the method of Lowry et al . 1951)
was 5mg/ml.
Milk. Fresh pasteurised cow's milk was
centrifuged (250xg, 10 minutes) to separate the bulk of
the fat and the aqueous layer diluted with medium to
the appropriate concentration. Protein content of the
aqueous layer was 35mg/ml (Lowry et al . 1951). No
problems with infection of cultures were found, despite
there being no sterilisation of the milk.
Bovine Serum Albumin (BSA). Lyophilised BSA




Final concentration of antigen was determined in
the case of gluten fraction III, milk, egg and BSA by
performing dose response studies in controls and
coeliacs. For gluten fraction III four controls and
four coeliacs were studied with final antigen
concentrations of between 200ug/ml and 4mg/ml .
Incubation time for the dose response studies was 20
hours. Both the leucocyte migration index and post-
culture leucocyte viability (assessed by trypan blue
exclusion (Boyse et al . 1964)) were used to determine
the appropriate concentration. Results of the
migration index study are given in Figure 3 and of the
viability data in Figure 4. At low antigen
concentrations (2 0 0 m g / m 1 and 5 0 0 u g / m 1) there is little
evidence of migration inhibition. At lmg/ml and 2mg/ml
there is inhibition of migration, especially of coeliac
leucocytes, though 2mg/ml also produces some inhibition
of normal cells. 4mg/ml inhibits both normal and
coeliac leucocytes and this is reflected in some loss
of viability (Fig. 4). A final concentration of lmg/ml
was thus chosen. This is in accord with previous work
(Bullen ft Losowsky, 1978).
For egg, milk and BSA similar studies were
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FIG. 3. Dose response in LMI test for gluten















FIG. 4. Dose response in LMI test using gluten
fraction III - leucocyte viabilities
after 20 hrs. culture
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final antigen concentrations of 1, 2 and 4mg/ml of BS A,
1 %, 2 % and 4% (v/v) of the stock egg white antigen
solution and 1%, 2% and 4% (v/v) of centrifuged milk.
Results for migration indices are given in Figure 5.
For BSA and egg the higher antigen concentrations
caused some inhibition of normal cells and final
concentrations of lmg/ml and 1 % (v/v) of stock solution
were chosen. In the case of milk there was little
difference between 1% and 2%. 1% was chosen largely
because the plates were more easily read as the culture
medium was less cloudy. Mean leucocyte viabilities
with the chosen final antigen concentrations were 91%
for egg, 93% for BSA and 93% for milk with normal
leucocytes and 92% for egg, 91% for BSA and 91% for
milk using coeliac leucocytes. Results at higher
antigen concentrations were similarly close, showing no
increased susceptibility of coeliac leucocytes to
toxicity of these antigens compared with controls.
PPD was used at a concentration of 200pg/ml (most
published studies use 100 - 300ug/ml). B2 was used at
lOug/ml to allow comparison with published results
(Ashkenazi et al. 1978). As only lOmg of this material
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FIG. 5. Dose response in LMI test with the
dietary antigens egg white, milk and BSA
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Duration of incubation. The optimal duration of
incubation was determined using gluten fraction III at
lmg/ml as antigen in four normal controls and four
coeliacs by measuring migration indices at 5-hour
intervals. Results are shown in Figure 6. Some
inhibition of migration of coeliac leucocytes is seen
as early as five hours but maximal separation of
coeliacs from controls occurs at 15 hours and 20
hours. Twenty hours was chosen as the standard
incubation time as it proved more convenient in
practice.
Reproducibility of LMI test
This was assessed in several ways. First, 14
individuals (9 controls and 5 coeliacs) had their
migration indices to gluten fraction III determined on
two separate occasions (without any alteration in
dietary status). The correlation between the first and
second results is shown in Figure 7. The correlation
is good, with a correlation coefficient r = 0.831,
(p<0.01). The same results are tabulated in Table 4.
From these results the calculated SD for duplicates is
0.0354, giving a coefficient of variation of 3.84%. It
can also be calculated that differences equal to or
greater than 1.96 x V~2~ x 0.0354 = 0.098 are unlikely to
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FIG. 7. Correlation between migration indices in
the LMI test using gluten fraction III on
14 individuals studied on 2 separate
occasions
TABLE 4
Results of migration indices to gluten fraction III in 14
individuals determined on two separate occasions
1st Migration Index 2nd Migration Index Difference
0.84 0.82 + .02
0.95 0.96 - .01
0.89 0.95 - .06
1 .08 1.17 - .09
0.92 0.92 0
0.86 0.91 - .05
0.76 0.80 - .04
0.95 0.99 - .04
0.92 0.88 + .04
0.96 0.96 0
0.89 0.84 + .05
1 .02 0.93 + .09
0.97 0.96 + .01
0.90 0.83 + .07
SD for duplicates =/^d2 = 0 .0354
v n
Coefficient of variation = = 0.0354 x 100% = 3.84%
overall mean 0.9225
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Second, one normal control had his miqration index
to gluten measured on six separate occasions. Results
are given in Table 5 and give a coefficient of
variation of 9%.
Finally, the coefficient of variation of the
migration areas of the quadruplicate wells was
calculated for 25 consecutively studied individuals (12
controls, 13 coeliacs) both for control cultures and
for those with gluten fraction III. The mean co¬
efficient of variation overall was 8.5% (range 0.1 -
16.4%). There was no difference between variability in
coeliacs versus controls nor for control medium versus
medium with added gluten.
Influence of HLA type and diet on LMI test using
gluten fraction III
Subjects. Fifty eight patients with coeliac
disease and 30 healthy controls were included in this
study. Twenty six of the patients were studied whilst
taking a normal diet. Coeliacs studied whilst on a
gluten-free diet were arbitrarily divided into an early
treatment group (gluten-free diet (GFD) for between 3
and 12 months) and a late treatment group (GFD for over
one year). Twenty five patients were studied whilst in
the early treated category (mean duration of GFD 6.2
months, range 3 - 11 months) and 32 whilst in the late
TABLE 5
Migration index to gluten fraction III in a normal








Coefficient of Variation = 9%
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treatment category (mean duration of GFD 5.4 years,
range 15 months - 10 years). Six patients were studied
serially at all stages of treatment.
HLA typing. Typing for A and B loci was performed
by the standard National Institute of Health, Bethesda
technique which is based on the micro1ymphocytotoxicity
technique of Terasaki & McLelland (1964). A bank of 60
sera was used. Typing was performed by the Regional
Blood Transfusion Centre, Leeds. All patients and
controls were typed for A and B loci.
DR typing was performed on 20 normal controls.
This was done by a modification of the 2-colour
fluorescence method of Van Rood et al . ( 1976 ) and was
performed by the University Department of Medicine at
the Royal Liverpool Hospital.
LMI test with gluten and other dietary antigens
LMI testing. LMI tests using gluten fraction III
and the dietary antigens egg white, milk and BSA (at
the concentrations described above) were simultaneously
performed on 28 coeliac patients (15 men and 13
women). Mean age was 36 years (range 12 - 60 years).
Ten patients were studied untreated; 10 were studied
early in treatment (mean duration of GFD 5.6 months,
range 4-8 months) including nine patients who had
been studied untreated; the remaining 16 patients were
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in the late treatment group (mean duration of GFD 5.3
years, range 15 months - 10 years). Twenty four
healthy controls of similar age and sex distribution
were also studied.
Jejunal morphology. Jejunal biopsies were
obtained from the region of the ligament of Treitz
using the Quinton capsule within 24 hours of performing
the LMI test in all 10 untreated coeliacs, eight of the
early treated group and 11 of the late treated group.
The biopsies were graded both by stereomicroscopic and
histological appearance (Scott, 1975) to allow changes
in immune responses to the dietary antigens to be
related to the jejunal villous morphology.
Biopsied controls. All 20 biopsied controls were
studied with all four dietary antigens. All were also
HLA typed for A and B loci.
Leucocyte inhibitory factor production by jejunal
mucosa
The relationship between production of leucocyte
inhibitory factors by jejunal mucosa and by peripheral
blood lymphocytes was investigated in 16 coeliac
patients (8 men, 8 women) by the simultaneous
performance of a direct LMI test with gluten fraction
III on blood leucocytes and an indirect LMI test using
cultured jejunal biopsies. Eight patients were studied
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whilst untreated and nine after treatment (mean
duration of GFD 2.7 years, range 8 months - 7 years).
One patient was studied untreated and after eight
months of treatment. The direct LMI test was performed
as described above.
Indirect LMI test. Jejunal biopsies from the
region of the ligament of Treitz were placed into organ
culture (details of the organ culture technique are
given later) with and without the addition of lmg/ml
gluten fraction III to the culture medium. After five
hours culture the medium was removed and stored at
-20°C until the indirect LMI test was performed. This
was done using leucocytes from a single healthy
control. The test was performed in the same way as the
direct LMI test but the culture medium used was that in
which the jejunal biopsies had been cultured. To
negate any non-specific action of gluten the control
medium was reconstituted with lmg/ml of gluten fraction
III. The only difference between the test and control
media was thus the presence of any factors produced by
the jejunal biopsy in response to being exposed to
gluten in culture. Migration index was thus calculated
as :
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Mean area of migration in test medium (from
Migration = biopsies cultured with gluten)
Index Mean area of migration in control medium
(gluten added after culture)
Comparison of B2 and gluten fraction III
A direct comparison of subfraction B2 and gluten
fraction III in the direct LMI test was made in 15
individuals (6 normal controls, 5 untreated coeliacs
and 4 coeliacs on treatment with gluten-free diet for
between 3 and 12 months). The concentration of B2 used
was that reported to be optimal in the aqar drop
system, i.e. lOyg/ml (Ashkenazi et al. 1978; 1980).
Gluten fraction III was used at lmg/ml.
Effect of rhamnose on LMI test with gluten
To assess whether gluten might be inhibiting the
migration of coeliac leucocytes by a lectin-like
binding to leucocyte cell membranes, six coeliac
patients (1 untreated, 5 on a gluten-free diet for a
mean of 5 months) were studied using the LMI test with
gluten fraction III with and without the addition of
the monosaccharide rhamnose (Sigma Chemicals Ltd.) at
5mmol/l. This concentration of rhamnose was chosen as
it was reported by Douglas (1976) to inhibit attachment
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of his gluten subtraction glyc-gli to cell membranes.
The effect of rhamnose alone at this concentration on
the migration of leucocytes was also investigated in
the same six patients.
Effect of puromycin on LMI test
Puromycin and other protein synthesis inhibitors
have been shown to block lymphokine-mediated inhibition
(Mitchell et al . 1972 ; Maini et al . 1973 ; Gorski,
1974). Its effect on results of the LMI test with
gluten were thus investigated. The method was first
validated using PPO - an antigen for which the
importance of T ce11-mediated responses is much better
documented.
Puromycin and the LMI test with PPD
Five normal controls were Mantoux-tested with 1
I.U. of PPD (St. James's University Hospital Pharmacy),
injected intradermally. The diameter of induration
produced was measured at 24 hours. Induration of
greater than 10mm was taken as a positive response.
The LMI test was performed using cells from these five
individuals with preservative-free PPD (Weybridge) at a
final concentration of 200ug/ml, with and without the
addition of puromycin (St. James's University Hospital
Pharmacy) at a final concentration of 15yg/ml. This
concentration of puromycin has been shown to be
effective in blocking lymphokine action (Mitchell et
al. 1972; Maini et al. 1973).
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Puromycin and the LMI test with gluten
The effect of puromycin at 15yg/ml on the LMI test
with gluten fraction III as antigen was investigated in
six normal controls and six coeliacs (1 untreated, 5
treated with a GFD for a mean of 8 months, range 4 - 12
months).
Puromycin at the concentration used has been
reported to inhibit leucocyte migration per se
(Mitchell et a1. 1972). This was checked in the 12
individuals studied in this series of experiments by
including a set of wells with added puromycin alone.
LMI test using sub-populations of leucocytes
This was performed to investigate the assumption
that results of the LMI test with gluten represent a
measure of T lymphocyte mediated immunity to gluten.
This was done by separating leucocytes into purified
populations of polymorphonuclear leucocytes
(polymorphs) and mononuclear cells, with subdivision of
the mononuclear cell population into T cell-enriched
and B eel 1-enriched populations. The LMI test was then
performed using purified polymorphs, purified mono¬
nuclear cells and polymorphs with added T cells and
with added B cells. Differential white cell counts on
mixed leucocytes prepared by the usual dextran
sedimentation method showed a mean of 63% polymorphs,
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33% lymphocytes and 4% eosinophils and monocytes.
Accordingly, in the experiments where T-enriched or
B-enriched lymphocytes were added to polymorphs this
was done in the proportion of 2:1 polymorphs:
lymphocytes in order to approximately reproduce the
proportions seen with the standard LMI test.
Separation of leucocyte subpopu1 ations
Mononuclear cells were separated from heparinised
venous blood by centrifugation at 400xg for 30 minutes
through Histopaque 1077 (Sigma Chemicals Ltd.) after
dilution of the blood with an equal volume of sterile
phosphate buffered saline of pH 7.2. The mononuclear
cells were aspirated from the interface. Mean yield of
—j
mononuclear cells from 30ml of blood was 3.2 x 10
cells. Differential counts showed >95% lymphocytes
with the remainder being monocytes. The red cell
pellets from beneath the Histopaque were combined with
minimal agitation and allowed to sediment at 37°C for
20 minutes. The po1ymorph-rich supernate was then
y
aspirated. Mean yield of polymorphs was 3.14 x 10
cells. Leishman stained smears of these preparations
showed >99% polymorphs with only occasional eosinophils
and no mononuclear cells. Aliquots of the mononuclear
cell preparation were taken for use in the LMI test and




This was achieved by differential centrifugation
through a Ficoll-Triosill solution after rosetting of
the T lymphocytes with neuraminidase treated sheep red
blood cells (based on the method of Weiner et a 1 .
1973). Five ml of 2% sheep red blood cells (SRBC)
(Oxoid Ltd.) in phosphate buffered saline (PBS) were
mixed with 15 0 y1 of 1 unit/ml neuraminidase
(Behringwerke AG, Marburg) and incubated at 37 0C for 30
minutes. The SRBC were then washed three times in PBS
and stored at 4°C until used. Fresh neuraminidase
treated SRBC were made up weekly. T-rosetting was
performed by mixing 2m 1 of 2% neuraminidase-treated
SRBC with 107 mononuclear cells and centrifuging at
200xg for 5 minutes. After one hour at room
temperature, the cell pellet was gently resuspended and
1.15ml Histopague introduced carefully under the cells
with a Pasteur pipette. After centrifugation at 800xg
for 20 minutes the rosetted T cells were pelleted under
the Histopague and the non-rosetted cells were at the
medium-Histopague interface. The SRBC were removed
from the T cells used 0.87% ammoniurn chloride. All
cell preparations were washed twice in medium before
use in the LMI test. Cell viabilities were always over
90% by trypan blue exclusion.
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The effectiveness of the T-B separation was
checked periodically by re-rosetting using neur¬
aminidase treated SRBC for T cells and with chromic
chloride treated fresh ox erythrocytes conjugated with
anti-human immunoglobulin for cells bearing surface
immunoglobulin (which were taken to be equivalent to B
cells). This is a modification of the method of Ling
et al. (1977). The T-enriched preparation always
contained >92% T cells and <5% B cells and the
B-enriched preparation >54% B cells (usually >70%) with
<10% T cells. Mean recovery of cells from the
rosetting procedure was 76%.
LMI test with subpopu1 ations of leucocytes using PPD
This was performed on four of the five controls
who were Mantoux tested as described above. Three were
Mantoux positive and one negative. All had a standard
LMI test with PPD as antigen at a concentration of
200yg/ml as well as the test performed with polymorphs,
mononuclear cells and polymorphs plus T cells and plus
B cells. (In one subject there were insufficient B
cells to perform a quadruplicate assay in this last
case).
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LMI test with subpopulations of leucocytes usinq
gluten fraction III.
Eight healthy controls and 10 coeliac patients
were studied. Five patients were studied untreated and
five after treatment with a gluten-free diet (mean
duration of GFD 11 months, range 6-15 months). As
with the parallel experiments usinq PPD, there were two
occasions when insufficient B cells were obtained and
three further occasions when, because of poor yield,
all the mononuclear cells had to be used in the T-B
separation procedure.
Serum incubation
To investigate whether a serum factor might be
involved in sensitising leucocytes to gluten, the LMI
test was performed with cells obtained by dextran
sedimentation from a normal control. These cells were
incubated with serum from six of the coeliac patients
(2 untreated, 4 treated) at 37°C for one hour at a
dilution of 1 in 2. The cells were then washed twice
in cold medium (to attempt to minimise elution of any
cytophilic antibody (Berk in & Benacerraf, 1966) and
used in the LMI test with gluten fraction III as usual.
Aliquots of the cells were also pre-incubated with
aggregated human I g G in an attempt to block Fc
receptors. The IgG (kindly supplied by Mr. P. Guillou,
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Department of Surgery, St. James's University Hospital)
at 64mg/ml was aggregated by heatinq to 63°C for 20
minutes and then incubated with the cells at 37°C for
one hour at a final concentration of 5.8mg/ml (this
concentration is sufficient to block Fc receptors in an
experimental ADCC system (Carnaud et al . 1980 )). The
cells were then washed twice in cold medium, incubated
with the coeliac sera as above, rewashed twice and used
in the LMI test.
Jejunal biopsy organ culture studies
General description of technique
Biopsies. All subjects studied were undergoing
jejunal biopsy as part of routine diagnostic
procedure. Biopsies were taken, with informed consent,
from the region of the liqament of Treitz after at
least a six-hour fast and after ensuring that there
were no significant abnormalities of platelet count or
prothrombin time, using the Quinton biopsy apparatus.
Multiple biopsies were taken routinely; the most
suitable specimens were sent for diagnostic histology
and the remainder used for organ culture studies.
Culture mediurn. The basic culture medium used was
that described by Ferguson et a 1 . (1975) and consisted
of Trowell's T8 medium (6ml), NCTC 135 medium (2ml), 1M
Hepes buffer (0.1ml) (all obtained from Flow
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Laboratories Ltd., Irvine), 200mM glutamine (0.2ml)
(Sigma Chemicals Ltd.), foetal calf serum (1.5ml)
(Wellcome Reagents Ltd.), 100 units oenicillin and 100
units streptomycin (Pharmacy, St. James's University
Hospital). This medium (the "control" medium) was
mixed freshly 1-2 hours before use in the organ culture
system and was kept at 3 7 0 C until the biopsies were
obtained.
Culture procedure. The biopsies, delivered by the
Ouinton apparatus in R i nger-Tyrode solution, were
immediately placed in ice-cold control medium and cut
into two pieces. The pieces were mounted with the
villous surface uppermost on wire grids and placed in
sterile organ culture dishes (Falcon Plastics Ltd.,
suppliers: Becton, Dickinson Ltd., Middlesex). The
central well was then filled with the appropriate
culture medium so that the medium just touched the
under-surface of the biopsy. This required
approximately 1ml of medium. Care was taken not to
"flood" the biopsy. The time from excision of the
biopsy to this point was approximately five minutes.
The outer ring of the culture dish contained an
absorbent paper ring which was saturated with sterile
water or normal saline to produce a humid atmosphere in
the culture dish.
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The dishes were then placed in a sterile anaerobic
jar which was gassed with 95% oxygen and 5% carbon
dioxide for 30 minutes, sealed and incubated at 3 7 0 C.
Jejunal biopsy and lymphocyte co-culture
Thirteen patients with treated coeliac disease and
five controls were studied. The patients (7 men, 6
women, mean age 35 years, range 22 - 55 years) had all
been on gluten-free diets for at least six months (mean
4.9 years, range 6 months - 10 years). The controls
were from the "biopsied control" group. All had
histologically normal jejunal biopsies. Final
diagnoses were irritable bowel syndrome (2), Crohn's
disease (1), food allergy (1) and dietary iron
deficient anaemia (1).
Lymphocyte preparation
Peripheral blood mononuclear cells were prepared
from 20ml of heparinised venous blood taken on the
morning of the biopsy by centrifugation through
Histopague 1077 as described above. Cells were washed
twice in Medium 199 and finally suspended at a
concentration of 5 x 106 cells per ml. 0.2ml of this
suspension was added to organ cultures to given 1 x 106
lymphocytes per culture. Organ cultures without added
lymphocytes had 0.2ml of Medium 199 added. Lymphocyte
viability was tested by trypan blue exclusion.
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Organ culture
Organ cultures of mucosal biopsies were set up as
described above. Duplicate cultures were set up in
control medium, in control medium with added
lymphocytes, in medium containing gluten fraction III
at lmg/ml and in medium containing gluten fraction III
with added lymphocytes. Cultures were terminated at 24
hours. One specimen was taken for quantitative
histology and the other for biochemical analysis. A
biopsy which had not been cultured was included in each
case and was processed with the post-culture specimens.
Quantitative histology
Objective assessment of histological change was
made by measurement of mean enterocyte height, using
the method described by Howdle et a 1 . (1981). All
slides were coded and randomised and all measurements
were made by a sinqle observer. The sections were
projected onto a screen using a Leitz microscope
projector at a magnification such that 1mm on the
projected image corresponded to In on the section. The
heights of at least 20 epithelial cells chosen randomly
from throughout the section were then measured from the
epithelial side of the basement membrane to the outer
edge of the brush border using a perspex ruler. Cells
measured were those with central, basally-placed
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nuclei. Areas which were tanqentially sectioned or
poorly preserved were avoided as were cells near crypts
or the tips of villi. The mean cell height was then
calculated. The precision of this measurement was
assessed by calculating the coefficient of variation
for the 20 measurements made on each section. Results
from 10 sections chosen at random and measured by one
observer are shown in Table 6. The mean coefficient of
variation for these individual results is 6.77% which
is very close to the 6.6% calculated from data of Marsh
(1972). The reproducibility of the assay was assessed
by measurement of 10 coded sections (from both coeliacs
and controls) in random order on two separate occasions
by a single observer. These results are given in Table
7. The calculated standard deviation for duplicates
from these results is 0.458y. It can thus be calcuated
that in this assay a difference in results of 0.458 x/2*
x 1.96 = 1. 2 7 u is unlikely to be due to observer error
with a probability level of p<0.05: (Campbell & Owen,
1967 ) .
Biochemical analysis
Specimens for biochemical analysis were
homogenised in 2ml of 0.9% saline with ten strokes of a
teflon pestle in a glass homogeniser (Thomas Co.U.S.A.)
and were then stored at -70°C before being assayed for
TABLE 6
Variability of mean enterocyte height measurement
on individual sections
Mean cell height(p) S.D. C.V.(%)
30.85 1.76 5.71
28.85 1.66 5.75
28.30 1.66 5 .87







Mean CV = 6.77%
TABLE 7
Enterocyte height measurements made by the same
observer on 10 sections on two separate occasions
Section 1st measurement 2nd measurement Difference
( um) ( um)
1 19.84 19.63 + 0.21
CM 26.79 27.52 - 0.73
3 21.22 21.25 - 0.03
4 26.70 26.10 + 0.60
5 28.04 28.65 - 0.61
6 19.95 20.53 - 0.58
7 24.67 24.95 - 0.28
00 28.00 28.29 - 0.29
9 24.48 25.85 - 1.37
10 19.57 20.24 - 0.71
SD = = 0.458
v n
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alkaline phosphatase activity, protein content and
DNA. Enzyme activities were then expressed either per
mg wet weight of biopsy, per mg of protein or per yg of
DNA.
Alkaline phosphatase assay
Alkaline phosphatase was estimated by the fluori-
metric method described by Peters et al . ( 1972 ) using
4-methyl umbelliferol phosphate (Sigma Chemicals Ltd.)
as substrate at pH 8.7 with 0.05M borate buffer
containing 5mM MgCl2- Assays were performed in
duplicate at a dilution of 1 in 20 (determined as
suitable by preliminary experiments) with solutions of
methyl umbel 1iferone (Sigma) of 1, 5 and lOnmol/ml as
standards (emission of standard solutions was shown to
be linear up to 50nmol/ml in preliminary experiments).
Both enzyme and substrate blanks were included in each
assay. Incubation period was 15 minutes and the
reaction was stopped by addition of sodium/glycine
buffer at pH 10.5. Fluorescence was read on an Aminco-
Bowman Spectrophotofluorimeter (American Instrument
Co.) at Excitation 365nm and Emission 460nm.
As it was impracticable to assay all specimens for
alkaline phosphatase fresh the effect of both freezing
and length of storage was investigated. Data were
available on 76 pairs of homogenates which had been
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assayed by the above technique both fresh and after a
single freezing with storage for a varied period.
Results show that for specimens measured in less than
seven days there is no significant deterioration; those
measured in seven days or less just fail to show
significant deterioration whereas those measured after
seven days do deteriorate significantly. Analysis of
29 pairs of results on samples analysed after one or
two freeze-thaw cycles show a significant deterioration
after the second freeze-thaw both for the whole group
and for 12 samples stored for less than seven days
(Howdle, personal communication). All results in this
thesis are from samples stored for less than seven days
and analysed after a single freeze-thaw cycle. Results
are expressed as milliunits, lmU corresponding to the
hydrolysis of lnmol of substrate per minute per mg of
protein in the same homogenate. Within batch variation
was estimated on five biopsies which were assayed with
at least eight replicates. Coefficients of variation
of these assays ranged from 5.0 to 11.2% which was
regarded as acceptable.
Protein assay
Protein was assayed in the biopsy homogenate using
the method of Lowry et al . (1951) using solutions of
bovine serum albumin (BDH Ltd.) as standards. The
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effect of storage was estimated on 29 sampies which had
been assayed twice with storage periods ranging from
four days to 15 months. Results are shown in Figure 8,
which shows the difference between the two assays
plotted against time. There is no trend for the
differences to vary from zero with increasing time of
storage and it was concluded that the assay was
unaffected by storage at -70°C. Within batch variation
was estimated on 12 replicates of a single homogenate
and gave a coefficient of variation of 2.9%.
DNA assay
DNA was measured using the fluorescent method of
Le Pecg & Paoletti (1966).
Phosphatidyl inositol turnover assay (I)
A method of assaying the incorporation of
tritiated myoinositol into cellular lipids as a measure
of phosphatidyl inositol turnover in cultured jejunal
biopsies was developed. This was based on the method
described by Ogmundsdottir & Weir (1979). A total of
31 patients undergoing routine jejunal biopsy for
diagnostic purposes was studied. Fifteen had normal
biopsies ("biopsied controls"), 10 were untreated
coeliacs and six treated coeliacs. Biopsies were taken
and set up in organ culture as described above, with
and without the addition of gluten fraction III to the


















culture medium at a concentration of lmq/ml , and with
the addition of 2 y C i of H-myoinositol (Radiochemical
Centre, Amersham) in PBS. The basis of the assay used
is simply extraction of all the lipid material in the
tissue studied. This lipid is then dissolved in an
organic scintillation fluid for counting. As the
labelled myoinositol is incorporated specifically into
phosphatidyl inositol no subfractionation of the lipid
is required. The method described by Ogmundsdottir &
Weir (1979) was designed for use with macrophage
monolayers and thus had to be modified for use with
organ culture of jejunal biopsies. Preliminary
experiments showed that the short culture periods
(after addinq the label) used with cell monolayers gave
poor incorporation of label using biopsies, perhaps
largely as a result of the relatively poor access of
label in the medium to the enterocytes of the surface
of the biopsy, which itself is floating on the surface
of the medium. To minimise disturbance of the organ
culture system, the labelled myoinositol was thus
incorporated into the medium from the start of the
culture period, which was 24 hours. At the end of this
time the cultures were terminated by immersing the
biopsies into ice-cold phosphate buffered saline (PBS,
pH 7.2). The biopsies were then washed thoroughly in
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cold PBS (5 changes of 5ml aliquots of PBS were used as
preliminary studies had demonstrated minimal radio¬
activity extracted into the PBS after this number of
changes). On the first 13 patients studied (7 biopsied
controls, 4 untreated coeliacs and 2 treated coeliacs)
the following procedure was then adopted. Each washed
biopsy was mopped dry, weighed and then transferred to
a glass homogeniser tube and 5ml of a 2:1 chloroform-
methanol mixture added. The biopsy was then homo¬
genised using ten strokes of a teflon pestle as
described above. The lipids were then extracted from
this homogenate by incubation at 37°C for 20 minutes
with vigorous shaking on a Whirlimixer every five
minutes. Two ml of liver lipid extract (prepared as
described below) and 3ml of 0.5M MgCl2 were than added
and mixed well. Addition of a lipid carrier reduces
loss of labelled lipid during extraction (Ogmundsdott i r
& Weir, 1979) whilst MgCl2 reduces the loss of polar
lipids into the aqueous phase (Folch et al. 1957).
After mixing, the phases were then separated by
centrifugation at 1000 rpm for 10 minutes. The aqueous
phase was then aspirated with a Pasteur pipette and
discarded and the organic phase equilibrated for 10
minutes against 3m 1 of 0.5M M g C1 2 without mixing. The
aqueous phase was once more discarded and the organic
phase carefully transferred into disposable liquid
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scintillation vials, taking care not to carry over any
droplets of the aqueous phase. The organic phase was
then evaporated to dryness at 45°C under a stream of
nitrogen. The dried extract was then dissolved in a
toluene based scintillation fluid containing 0.4% 2,5
diphenyloxazole (POP) and 0.01% 1,4 di (2,5 pheny-
loxazole) benzene (P0P0P) (both from BDH Ltd.). Radio¬
activity was then counted for 10 minutes in a Packard
Tri-Carb Liquid Scintillation Spectophotofluorimeter
Model 3375.
Extraction of lipid carrier
Twenty five grams of rat liver were homogenised in
50ml of a 2:1 ch1oroform-methano1 mixture and extracted
at 37 °C for 20 minutes. Twenty five ml of 0.5M MgCl2
was added and thoroughly mixed. The mixture was then
centrifuged at 300xq for 10 minutes. The aaueous phase
was discarded and the organic phase withdrawn from
beneath the compacted liver tissue with a Pasteur
pipette. The organic phase was then equilibrated for
10 minutes with 0.5M MgCl2 without mixing, spun at
300xg for 10 minutes and the aqueous phase discarded.
The organic phase was dried with a little anhydrous
Na2S0tt and evaporated to dryness at 45°C under a stream
of N2. The residue was then dissolved in 50ml of 2:1
ch1oroform-methano1 and stored in 1ml aliquots at
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- 2 00 C. For use in the lipid extraction this solution
was diluted one part in 10 with 2:1 chloroform-
met h ano 1 .
Reproducibility of assay
The above assay was used on biopsies from 13
patients. In each case the organ cultures with and
without added GFIII were performed in duplicate.
Results were expressed as counts per minute per mg of
tissue (cpm/mg) in the first instance. Results are
shown in Appendix Table 1. The results are obviously
extremely variable and the coefficient of variation
from duplicates is 87.1%. Even when the seven most
obviously abnormal results are excluded, the C.V. is
26.5% which is clearly unacceptable.
There were two main reasons for this variability.
Firstly, perhaps because of the low surface
tension of the chloroform-methanol, it was extremely
difficult to adequately homogenise biopsies in this
medium and splashing and loss of solute were common and
almost impossible to avoid. Secondly, the wet weight
of the biopsy was difficult to measure with any
precision as in order to remove all visible surface
fluid from the biopsies the mopping technique (usinq
blotting paper) tended to remove a variable amount of
surface mucus. The method was thus altered to remove
these sources of error.
115
PI turnover assay (II)
The biopsy cultures were set up and terminated as
described above. The biopsies were then homogenised in
2ml of normal saline. Aliquots of 0.5ml of homogenate
were then incubated at 37°C for 20 minutes after
addition of 2.5ml of chloroform-methanol and the lipid
extraction then proceeded as described above. The
remaining homogenate was stored at -70°C for later
protein estimation, which was performed by the Lowry
technique. Radioactive counts were converted into
disintegrations per minute (dpm) by use of a standard
Quench curve (see below) and results expressed as
dpm/mg protein.
Reproducibility of assay
This assay was used on samples from 18 patients.
Eight were biopsied controls, six untreated coeliacs
and four treated coeliacs. One sample was spilt and a
duplicate assay could thus not be performed. There are
thus 70 pairs of duplicate observations available and
these are shown in Appendix Table 2. The calculated
C.V. for duplicates in these results is 7.7% which was
felt to be acceptable.
Quench curve
This was derived using a ^ H standard (LKB-Wallace












by sequential additions of lul aliquots of carbon
tetrachloride using the scintillation fluid described
above. The tritium standard was rated as producing
209,500 dpm. This figure was adjusted for decay using
the formula:
N = No exp (0.693t)
t
Results are shown in Appendix Table 3 and Figure 9.
Use of this curve enabled results expressed as counts
per minute to be converted to disintegrations per
minute allowing for the efficiency of counting.
RESULTS
"One should always be a little improbable"
Phrases & Philosophies for the Use of the Young
Oscar Wilde, 1894
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LMI test with gluten fraction III - influence of
HLA-B8 and diet
Results of the LMI test in 30 normal controls with
gluten fraction III as antigen are shown in Figure 10.
Fourteen of the controls had the histocompatibility
antigen HLA-B8 and 16 did not. Those having HI.A-B8 had
a mean migration index of 0.88 (range 0.78 - 1.02; SD
0.08). Those lacking HLA-B8 had a mean migration index
of 0.98 (range 0.80 - 1.17; SD 0.10). Using Student's
t test, there is a significant difference between these
groups (p<0.02) indicating significantly greater
immunity in the HLA-B8 group, though there is a great
overlap.
Figure 11 shows the results of the LMI test with
gluten fraction III in 27 untreated coeliacs divided
into 22 having HLA-B8 and five lacking this antigen,
compared with the 14 HLA-R8 controls. Mean migration
index for the HLA-B8 coeliacs was 0.88 (range 0.66 -
1.14; SD 0.12) and for the non-HLA-B8 coeliacs 0.91
(range 0.75 - 1.14; SD 0.15). Neither of these groups
differ significantly from the HLA-B8 controls (though
they do when compared with the non-HLA-B8 controls, nor


















FIGo 10. Migration indices to gluten fraction III
in 30 healthy controls divided according


















FIG. 11. Migration indices to gluten fraction III
in 27 untreated coeliacs divided according
to possession of HLA-B8 compared with 14
normal controls having HLA-B8
\
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Figure 12 shows the results of the LMI test for
all the coeliac patients studied divided according to
HLA-B8 status and by treatment status. Coeliacs early
in treatment (gluten-free diet for 3-12 months) had
significantly lower migration indices than the
untreated group (B8: mean 0.79, SD 0.06; non-B8: mean
0.76, SD 0.05, p<0.01). The group on treatment for
over 12 months ("late treated") showed a significant
increase in migration indices (B8: mean 0.88, SD 0.09;
non-B8: mean 0.88, SD 0.06, p<0.01) and gave values
indistinguishable from HLA-B8 controls or from
untreated coeliacs. It is noteworthy that coeliacs
having HLA-B8 and those lacking HLA-B8 give similar
results at all stages and respond similarly to changes
in dietary status.
Results from the six coeliac patients studied at
all stages of treatment are shown in Figure 13 and show
a similar pattern of a fall in migration index early in
treatment and a later rise. This holds for B8 and
non-B8 individuals.
Influence of DR3
Results from the 20 normal controls typed for the
DR3 histocompatibility antigen are shown in Figure 14.
The seven subjects with DR3 gave a mean migration index






























FIG. 12. Migration indices to gluten fraction III in
58 coeliacs divided according to HLA-B8 status,
and dietary status.
('Early treated' = gluten free diet for
3 to 12 months
'Late-treated' = gluten free diet for
over 12 months)
• • B8
FIG. 13. Migration indices to gluten fraction III









FIG. 14. Migration indices to gluten fraction III
in 20 normal controls divided according
to possession of the DR3 antigen
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DR3 gave a mean migration index of 0.95 (range 0.80 -
1.17, SD 0.12). The DR3 group thus have a lower mean
value but do not significantly differ statistically
from the non DR3 group.
LMI test with other dietary antigens
Results of the LMI test in controls and coeliacs
(sub-divided by dietary status and HLA-B8 status) to
the dietary antigens egg, bovine serum albumin and milk
are shown in Figures 15 - 17. Considering the results
from the normal controls first, it can be seen that the
possession or lack of HLA-B8 does not seem to influence
migration indices to egg (mean HLA-B8 0.93, non-B8
0.98), to BSA (mean HLA-B8 0.97, non-B8 1.02) or milk
(mean HLA-B8 0.97, non-B8 0.98). In all three cases
there is no statistically significant difference
between the HLA-B8 and non-HLA-B8 groups. Furthermore,
though the numbers of HLA-B8 neqative coeliacs were too
low to allow valid statistical comparison with HLA-B8
coeliacs, the responses of the two groups were similar
for each antigen at each stage of treatment. HLA-B8
status was thus disregarded in subsequent statistical
analysis of results for egg, BSA and milk antigens.
With egg antigen there is a significant difference
between migration indices of controls (mean 0.96) and






































FIG. 15. Migration indices to egg antigen in controls
and coeliacs at various stages of treatment










































FIG. 16. Migration indices to bovine serum albumin
in controls and coeliacs at various stages






































FIG. 17. Migration indices to milk antigen in
controls and coeliacs at various stages
of treatment divided according to
possession of HLA-B8
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rank sum test). The late treated group was
indistinguishable from controls (mean 0.97) and also
differed significantly from the untreated group
(p<0.01). The early treated group occupied an
intermediate position (mean 0.90).
Results with BSA were similar: untreated coeliacs
(mean migration index 0.90) differed from controls
(mean 0.99, p<0.05 by Wilcoxon's rank sum test) and
from patients treated for over one year (mean 1.00;
p<0.05) with the early treated group in an intermediate
position (mean 0.94).
In the case of the milk antigen, there were no
significant differences between the groups, mean
migration indices being: controls 0.98; untreated
coeliacs 0.99; early treated coeliacs 1.01; late
treated coeliacs 0.96.
The same subjects were also studied with gluten
fraction III and results are shown in Figure 18. Here
a different pattern is seen with significantly lower
migration indices in the HLA-B8 normal controls (mean
0.88) compared with controls lacking this antigen (mean
0.98, p<0.05 by Wilcoxon's test). Untreated coeliacs
(mean 0.87) differed significantly from HLA-B8 negative
controls (p = 0.05) but not from the HLA-B8 controls.





































FIG. 18. Migration indices to gluten fraction III
in those controls and coeliacs.included
in studies with other dietary antigens
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of 0.75, which differed significantly from both
untreated coeliacs (p<0.01) and the late treated group
(mean 0.85, p<0.01). HLA-B8 and non-HLA-B8 coeliacs
gave similar results in each group. These results are
in close accord with those presented above (see Figures
10 - 12).
Figure 19 illustrates the migration indices to
each of the four dietary antigens studied for the 10
untreated coeliacs. The line at migration index 0.80
represents the level below which it is conventionally
accepted that definite cell-mediated immunity is
demonstrated. This convention in fact agrees well with
the normal ranges (calculated as mean ± 2SD) derived
from the results of the normal control group for all
antigens, except in the case of gluten fraction III
where the influence of HLA-B8 affects the "normal"
range. Using this conventional criterion, four of the
10 coeliacs have cellular immunity to egg antigen, two
to BSA, one to milk and two to gluten fraction III.
Jejunal biopsies. Results of grading of jejunal
biopsies by stereomicroscopic appearance are shown in
Table 8 and by histological appearance in Table 9.
There is a clear improvement in morphology by both
criteria in the early treated group compared with the




































FIG. 19. Migration indices to four dietary antigens
in 10 untreated coeliac patients
TABLE 8
Stereomicroscopic grading of jejunal biopsies
Untreated Early treated Late treated
coeliacs coeliacs coeliacs
(n = 10) (n =8) (n = 11)
Flat 9 0 0
Convoluted 1 20
Ridged 0 4 1
Villous 0 2 10
TABLE 9
Histological grading of jejunal biopsies
(SVA = subtotal villous atrophy.
PVA = partial villous atrophy)
Untreated Early treated Late treated
coeliacs coeliacs coeliacs
(n = 10) (n =8) (n = 11)
SVA 5 00
Severe PVA 5 41
Mild PVA 0 3 4
Normal v i 11 i 0 1 6
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Comparison of normal control and biopsied control
groups
Figure 20 illustrates the comparison of results to
all four dietary antigens between the group of normal
controls and the group of biopsied controls. The two
groups give similar results for all antigens. The only
notable difference is the lack of a statistically
significant difference between HLA-B8 biopsied controls
(mean 0.88) and non-HLA-B8 biopsied controls (mean
0.94) with gluten fraction III as antigen, though the
trend towards lower values in the HLA-B8 group is still
evident.
Comparison of two subtractions of gluten as antigens in
the LMI test
Figure 21 shows the results of the LMI test using
the B2 subtraction of gluten in the six controls and
nine coeliacs studied. Mean migration index for the
control group was 1.02 (range 0.87 - 1.09 ), for the
five untreated coeliacs 0.99 (range 0.92 - 1.04), for
the four treated coeliacs 1.04 (range 0.90 - 1.17) and
for the coeliac group as a whole 1.01. There is thus
no discrimination between these groups with this
antigen in this system.
All 15 subjects were studied with gluten fraction
III and the correlation of results with B2 and with
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FIG. 21. Migration indices to the B2 gluten
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FIG. 22. Correlation between migration indices
to gluten fraction III and B2 subfraction
in normal controls and coeliacs
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gluten fraction III results were compatible with those
reported above, mean migration indices being: controls
0.95, untreated coeliacs 0.85, treated coeliacs 0.85.
There is no correlation between B2 and GFIII results
(r = 0.22, p>0.5).
Effect of rhamnose on LMI test
The effect on migration index to gluten fraction
III of the incorporation of 5mmol rhamnose is shown in
Figure 23. Mean migration index with gluten fraction
III alone was 0.79 and with rhamnose and gluten
fraction III 0.81. There was no significant chanqe in
migration index for any individual nor for the group as
a whole.
Migration studies with rhamnose alone showed no
effect of rhamnose alone on leucocyte migration, mean
migration index being 1.03 (range 0.97 - 1.10).
Effect of puromycin on LMI test
1) Effect of puromycin alone
The effect of puromycin alone on leucocyte
migration is shown in Figure 24. Migration areas for
both normal controls and coeliac patients are similar






FIG. 23. Effect of 5mmol rhamose on migration






















FIG. 24. Effect of puromycin at 15|ig/ml on
leucocyte migration areas in normal
controls and coeliacs
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2) Effect on the LMI test with PPD
Of the five normal subjects tested, three
proved to be Mantoux-positive and two Mantoux-
negative. Results of the L MI test with PPD as antigen,
with and without incorporation of puromycin into the
culture medium, are shown in Figure 25. In the absence
of puromycin all three Mantoux-positive subjects show
inhibition of leucocyte migration by PPD (migration
indices less than 0.8) whilst the Mantoux-negative
subjects have migration indices approximating to unity,
i.e. there is no migration inhibition. The results in
the Mantoux-positive subjects show a marked increase in
migration index to PPD in the presence of puromycin,
that is, inhibition of leucocyte migration by PPD seems
to be blocked by puromycin.
3) Effect on the LMI test with GFIII
The effect of puromycin on migration indices
to gluten fraction III in six normal controls and six
coeliacs (one untreated, five on a gluten-free diet) is
shown in Figure 26. In contrast to the results with
PPD there is no trend towards an increase in migration
index to approach unity when puromycin is included in
the culture medium.













FIG. 25. Migration indices to PPD in 3 Mantoux
positive and 2 Mantoux negative subjects
with and without the addition of puromycin
at 15pg/ml to the culture medium
1-1 ® Coeliac - normal diet
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FIG. 26. Migration indices to gluten fraction III
in 6 normal controls, one untreated coeliac
and 5 treated co'eliacs with and without the
addition of puromycin at 15|ig/ml to the
culture medium
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LMI test using subpopu1 ations of leucocytes
1) Using PPD as antigen
Figure 27 illustrates the results of the LMI
test performed in the standard manner and with purified
polymorphonuclear leucocytes, purified mononuclear
cells and purified polymorphs with added T lymphocytes
and with added B lymphocytes, using PPD as the antigen
in three Mantoux-positive and one Mantoux-negative
subjects. Significant migration inhibition of cells
from the Mantoux-positive subjects is seen only in the
standard test and in the test using polymorphs with
added T cells. Polymorphs alone, mononuclear cells
alone and polymorphs with B cells show no inhibition.
2) Using gluten fraction III
Figure 28 shows migration indices to gluten
fraction III for eight controls, five untreated
coeliacs and five treated coeliacs using the standard
LMI test and the test performed with the same cell
types as in Figure 27. With the standard test the
coeliac patients show a significant reduction of
migration index compared with controls (mean migration
index for coeliacs 0.84, mean for controls 0.91, p<0.05
by Wilcoxon's rank sum test). However, a similar
difference is seen when the test is performed with
polymorphs only (mean for coeliacs 0.86, controls 0.99,
• Mantoux ( + )
O Mantoux (-)
M
Standard Polymorphs Mononuclear Polymorphs Polymorphs
















FIG. 27. Migration indices to PPD in 3 Mantoux
positive and one Mantoux negative
individuals using the standard LMI
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p < 0 .0 5 ). Mononuclear cells alone were not inhibited
either in coeliacs or controls (means: coeliacs 0.96,
controls 0.96). When the test was performed with
polymorphs with added T cells results were similar to
those with polymorphs alone (means: coeliacs 0.89,
controls 0.97) and this also held with results using
polymorphs with added B cells (means: coeliacs 0.91,
controls 0.94) though the difference between controls
and coeliacs fails to reach statistical significance
using these cell combinations.
Figure 29 shows the correlation between individual
migration indices to gluten fraction III using the
standard LMI test and that performed with purified
polymorphs. There is a significant correlation between
the results of the two tests using both parametric and
non-parametric tests (r = 0.62, t = 3.2, p<0.01;
Spearman's rank correlation coefficient = 0.64,
p<0.01). Furthermore, the slope of the line of best
fit is 0.91 with a standard deviation of the slope of
0.28. The slope does not, therefore, differ
significantly from unity (t = 0.33) nor does the
intercept differ significantly from zero (y intercept =
0.13, SD = 0.24, t = 0.53) .
Figure 30 shows a similar correlation between the
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FIG.29. Correlation between migration indices with
gluten fraction III as antigen in controls
and coeliacs using the standard LMI test
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FIG. 30. Correlation between migration indices
with gluten fraction III as antigen in
controls and coeliacs using the standard
Lftl test and the LMI test performed with
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FIG. 31. Correlation between migration indices
with gluten fraction III as antigen in
controls and coeliacs using the LMI test
performed with purified polymorphs and
with polymorphs with added T cells
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with added T cells. There is again a significant
correlation between results (r = 0.66, p<0.005).
Figure 31 shows the correlation between results of the
tests performed with polymorphs alone and with
polymorphs with added T cells. This too is significant
(r = 0.67, p<0.005). There are similar positive
correlations between results of the test performed with
polymorphs with the test performed with polymorphs plus
B cells (r = 0.74, p<0.005) and between the test with
polymorphs plus T cells and that with polymorphs plus B
cells (r = 0.65, p <0.01). There is thus no apparent
effect on the results of the test by incorporation of T
cells or B cells into the system.
Effect of serum incubation on LMI test
The effect of incubation with sera from six
coeliac patients on the migration index of leucocytes
from a single healthy control is shown in Figure 32.
Cells from the control subject consistently gave a
migration index with gluten fraction III of around 0.9
(mean of 4 experiments 0.91, SO 0.02). After
incubation with coeliac sera and washing, however, the
cells were markedly inhibited by gluten fraction III
(mean migration index 0.75, SD 0.05). This
sensitisation to gluten was prevented by incubation
with aggregated human I g G before incubation with the










FIG. 32. Effect of incubation with coeliac sera
on migration index of normal leucocytes
with gluten fraction III as antigen and
effect of pre-incubation with aggregated
human IgG
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Leucocyte inhibitory factor production by jejunal
mucosa
The correlation between results of the direct LMI
test using peripheral blood leucocytes and of the
indirect LMI test to assess production of leucocyte
inhibitory factors by cultured jejunal mucosa in 16
coeliac patients is shown in Figure 33. There is a
significant inverse correlation between blood and
biopsy results (r = 0.56, t = 2.58, p<0.025); that is,
when there is marked production of inhibitory factors
by the jejunal biopsy, blood leucocytes do not show
such inhibition; when there is little inhibition in the
indirect test usinq the biopsy, blood leucocytes are
likely to be inhibited in the direct test. Figure 34
shows the results of the two tests performed on a
single coeliac patient, both untreated and after eight
months on a gluten-free diet. Initially the direct
test shows little inhibition (migration index 0.92)
whereas there is evidence of inhibitory factor
production by jejunal mucosa (indirect migration index
0.77). After eight months treatment the position is
reversed, direct migration index falling to 0.79 whilst
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FIG. 33. Correlation (with lines of best fit)
between the direct LMI test with blood
leucocytes and the indirect LMI test
with cultured jejunal biopsies in 16
cpeliacs with gluten fraction III as
antigen
Untreated Treated
FIG. 34. Migration indices to gluten fraction III
for the direct LMI test with blood
leucocytes and the indirect test with
cultured jejunal biopsies in a single
coeliac patient studied untreated and
after 8 months of gluten-exclusion
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Jejunal biopsy and lymphocyte co-culture
Histology
Full results of quantitative histological
assessment of the biopsies pre-culture and after
culture in control medium, medium with added gluten
fraction III, added lymphocytes and added gluten with
added lymphocytes are given in Table 4 of the Appendix.
Figure 35 illustrates the enterocyte heights of
biopsies from coeliac patients before culture and after
24hr culture in control medium. Mean enterocyte height
before culture was 29.ly and after culture 25.4y. This
difference is significant by both Wilcoxon's rank sum
test (p<0.01) and Student's t test (p<0.001).
(Appendix Table 4 gives statistical significance
results using the t test; Figures in the text give
results from Wilcoxon's test).
Figure 36 shows results comparinq biopsies
cultured in control medium with those cultured with
gluten fraction III alone and with lymphocytes alone.
Mean enterocyte height of biopsies cultured with
lymphocytes was 24.6y (3.1% lower than that of biopsies
cultured in control medium). Mean enterocyte height of
biopsies cultured with gluten fraction III was 2 4.7 y
(2.8% lower than biopsies cultured in control medium).
Neither of these differences is statistically
FIG. 35. Enterocyte heights of biopsies from
co'eliac patients before and after
24 hour culture in control medium
Enterocyte heights of biopsies from coeliac
patients after 24 hour culture in control
medium compared with enterocyte heights after
culture in medium with added lymphocytes alone






















significant by either statistical test. Biopsies
cultured with added gluten and with added lymphocytes
had a mean enterocyte height of 23. ly (Figure 37).
This represents a 9.1% reduction compared with biopsies
cultured in control medium and is significant (p <0.01
by Wilcoxon's rank sum test, p<0.001 by Student's t
test). Figure 38 compares biopsies cultured in the
presence of both gluten and lymphocytes with biopsies
cultured with added gluten alone and with added
lymphocytes alone. Mean enterocyte height of biopsies
cultured with gluten and lymphocytes was significantly
lower than both that of those cultured with gluten
alone (p<0.01 by Wilcoxon's test, p<0.02 by Student's t
test) and those cultured with lymphocytes alone (p<0.01
by Wilcoxon's test, p<0.005 by Student's t test).
The non-coeliac controls showed a similar
reduction in enterocyte height after culture in control
medium (mean 27.6u) compared with preculture values
(mean 30.75m) as did the coeliac patients. However,
there were no significant differences in enterocyte
height between biopsies from normal controls cultured
in control medium, with gluten, with lymphocytes and






FIG. 37. Enterocyte heights of biopsies from coeliac
patients after 24 hour culture" in control
medium and after culture in medium with added
gluten fraction III and added lymphocytes
FIG. 38. Enterocyte heights of biopsies from coeliac
patients cultured in medium with added gluten
and added lymphocytes compared with enterocyte
heights when cultured with added gluten alone







Enterocyte heights or biopsies from control
subjects after 24 hour culture in control
medium and after culture in medium with
added gluten and added lymphocytes
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Figure 40 illustrates a section from a biopsy from
a treated coeliac patient after 2 4 h r s culture in
control medium. The biopsy is well preserved and the
epithelial cell layer is regular. Figure 41 shows a
section from a biopsy from the same patient cultured
for 24hrs in the presence of gluten fraction III and
autologous lymphocytes. There is obvious morphological
deterioration and, in particular, the epithelial cells
are disorganised, irregular and of reduced height.
These changes are more clearly seen in the higher power
views in Figures 42 and 43 which also show typical
enterocytes chosen for measurement of epithelial cell
height. Figure 44 shows a biopsy from a normal control
cultured with gluten and lymphocytes. In contrast to
Figure 41, this biopsy is well preserved and the
epithelial cells remain normal.
Leucocyte migration indices for the 13 coeliac
patients are shown in Table 10, together with the
differences in mean enterocyte height between specimens
cultured in control medium and those cultured with
gluten and lymphocytes and the differences between
specimens cultured with gluten alone and those cultured
with gluten and lymphocytes. There is no correlation
between migration index and differences in enterocyte
height either for biopsies cultured in control medium
FIG'.0.
Biopsyfr mtreatedcoeliacpatientaft r24h u cultureincont olmedium (Haematoxylin&eosin.100)
FIG.41.
Biopsyfromtreatedc eliacp tientaf r24h ucul ure inmediumwithad edglut nniaddedlymphocy s (Haematoxylin&eosi .x100)
FIG.42.Biopsyfromtreatedcoeliacpatientaf r24h uculturein controlmedium.Arrowindicatestypicalte cytemeasured (Haematoxylin&e si .250)
.43.Biopsyfrorrsamep tientsinF gu2ft r24h r cultureinmediumwithaddedglut nndt lymphocytes.Arrowindicattypicalenterocytemeasured (Haematoxylin&e si .x250)
FIG,44.Biopsyfromnormalc ntrolafter24h ucul u e inmediumwithaddedglut nnly phocytes (Haematoxylin&e si .x100)
TABLE 10
Leucocyte migration indices to gluten fraction III antigen
in treated coeliac biopsies and differences in enterocyte
height between jejunal biopsies cultured in control medium
and those cultured with gluten and lymphocytes ((C)-(+G+L))
and of biopsies cultured with gluten alone and those
cultured with gluten and lymphocytes ((+G)-(+ G + L ))
PATIENT LEUCOCYTE MIGRATION ENTEROCYTE HEIGHT CHANGES (y)
INDEX (C)-( + G + L) (+GM+G + L)
1 0.74 +2.55 +0.82
no 0.71 + 1.70 + 1.75
3 0.92 +0.70 +0.20
4 0.80 -1.35 + 1 .80
5 0.91 +0.50 -0.30
6 0.91 + 3.56 +1.31
7 0.68 + 1.85 + 5.10
00 0.91 + 5 .15 + 6.60
9 0.76 + 3.25 +0.05
10 0.77 +2.75 + 2 .60
11 0.87 +3.60 0
12 0.86 + 2 .25 -0.10
13 0.89 +4.24 + 1 .44
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compared with those cultured with gluten and
lymphocytes (Kendall's rank correlation t = 0.22,
p>0.1) or for biopsies cultured in gluten-containing
medium compared with those cultured with gluten and
lymphocytes (t = 0.29, p>0.1).
Alkaline phosphatase
Full results of alkaline phosphatase assays on the
cultured jejunal biopsies are given in the Appendix
Tables 5-7 with results expressed in relation to the
protein content, wet weight and DNA content of the
biopsies. Mean alkaline phosphatase activity in the
pre-culture biopsies was 38.3mU/mg.protein (SD 20.8).
After culture for 24hrs this rose to 59.9 mU/mg.protein
(SD 27.9) for specimens cultured in control medium, to
64.2mU/mg.protein (SD 36.9) for specimens cultured with
lymphocytes, to 59.8mU/mg. protein (SD 37.9) for
specimens cultured with gluten alone and to
55.OmU/mg.protein (SD 28.6) for specimens cultured with
gluten and lymphocytes. There were no significant
differences between any of the post-culture values and
this also applies to the results when expressed in
relation to wet weight of biopsy or to DNA content of
the biopsy.
Lymphocyte viabilities
Viability of lymphocytes after 24hr culture with
jejunal biopsies was always over 90%.
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Phosphatidyl Inositol Turnover
Results of phosphatidyl inositol turnover as
assessed by uptake of labelled myoinositol by jejunal
biopsies cultured in the presence and absence of gluten
fraction III for healthy controls, untreated coeliacs
and treated coeliacs are shown in Figure 45, with the
turnover expressed as disintegrations per minute per ma
of protein. Mean value for healthy controls in the
absence of gluten was 68.1 x 103 dpm/mg.protein and in
the presence of gluten 74.5 x 103 dpm.mg.protein. For
biopsies from untreated coeliacs the mean values were
83.7 x 103 dpm/mg.protein in control medium and 81.7 x
103dpm/mg.protein in gluten-containing medium. The
treated coeliacs gave results of 79.0 x 103 dpm/mg.
protein in control medium and 82.2 x 103 dpm/mg.protein
in gluten-containing medium. Results for the same
groups expressed as an index (calculated as radioactive
uptake in the presence of gluten divided by uptake in
control medium) are shown in Figure 46.
There are no differences between the diagnostic
groups either in absolute levels of radioactive uptake
nor in the effect of gluten on the uptake. There is,
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FIG. 45. Phosphatidyl inositol turnovers for jejunal
biopsies cultured with and without gluten
fraction III in controls, untreated coeliacs
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FIG. 46. Phosphatidyl inositol turnovers for jejunal
biopsies from controls, untreated coeliacs •
and treated coeliacs expressed as a ratio of
radioactive uptake in the presence of gluten
to uptake in control medium (PIT index)
DISCUSSION
"Possibly the result may have been brought about by
the natural obstinacy of all things in this world"
Three Men in a Boat
Jerome K. Jerome, 1889.
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The LMI test
A large part of this thesis is concerned with the
use and interpretation of the leucocyte migration
inhibition test in coeliac disease. A considerable
effort was therefore expended in making sure that the
test was reproducible and that factors known to
influence results factitiously were excluded (Maini et
a 1 . 1973). From the results shown in Figure 7 and
Table 4, it can be seen that this was successful. In
the absence of dietary changes known to influence
results the test is shown to give consistent results
when individuals are tested repeatedly and it was
possible to calculate the magnitude of the change in
migration index in this system which is statistically
unlikely to be due to chance at the S% level. This is
calculated at just under 0.1. Whatever the test is
measuring it is at least measuring it consistently.
These results conflict with those reported by the
Glasgow group (Filer et al . 1981; Pattison et al . 1981)
who studied both agarose microdroplet and capillary
tube methods of performing the LMI test and concluded
that at least 30 replicates were required to have
confidence that mean migration area of a set of
replicate cultures was within 5% of the true mean for
either system. Much of the argument used by the
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Glasgow group is, however, based on computer simulation
of experimental results and is concerned with areas of
migration rather than migration indices. When the
latter are discussed the emphasis is on the statistical
validity of a single result, whereas in this study
almost all of the conclusions are drawn from
comparisons between groups of patients. Furthermore,
the variability of the migration areas which is quoted
by the Glasgow workers for the capillary tube method
(coefficient of variation from 7.7% to 28.8% calculated
on 15-26 replicates) seems large compared with the 0.1
16.4% (on quadruplicate cultures) in this study,
perhaps suggesting that not enough attention was paid
to the technical details discussed in the Methods
section.
The dose-response to gluten fraction III and time-
course experiments in this study gave results very
similar to previous workers (Bullen & Losowsky, 1978b;
Haeney & Asquith, 1978) and at the concentrations
chosen for study no antigen showed significant toxicity
nor any tendency for selective toxicity to coeliac
lymphocytes. The criticism that results of any
miqration inhibition test may be due to "non-specific"
toxicity affecting cell motility is, of course,
unanswerable as "non-specific" inhibition in the
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patient group cannot be assessed. However, the changes
in migration inhibition produced by the various
manipulations such as pre-incubation with coeliac serum
(which sensitises normal leucocytes to gluten but does
not affect their migration in control medium) and the
blocking of this effect by IgG does suggest that such
an explanation is unlikely and that the test is indeed
reflecting some immunological phenomenon.
Leaving aside for the moment the results
pertaining to the mechanism by which gluten affects the
migration of leucocytes from coeliac patients (i.e.
precisely what immunological phenomenon is being
measured by the test) what of the other problems
outlined in the Introduction relating to the
interpretation of LMI test results in coeliac disease?
First, what of the diagnostic power of the test? The
results presented here are in line with most of the
published work on the direct LMI test - that is they
show that even if HLA status is ignored, the test does
not separate coeliac and non-coeliac groups which,
though they differ statistically, overlap to such an
extent that the test is unlikely to aid diagnosis in an
individual case. In this regard, it is important to
note that the differences between controls and coeliacs
are less when the coeliacs are taking a normal (gluten-
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containing) diet, which is, of course, the case when a
diagnostic problem in an individual case occurs. The
suggestion that suspected coeliac patients should be
given a gluten-free diet for some months to increase
the power of the test (Ashkenazi et a1. 1981) cannot be
taken seriously as, apart from the unwieldiness of such
a diagnostic procedure, no data exist on the effect of
such a diet on the LMI test results of normal
individuals.
Also of relevance to the diagnostic power of the
LMI test are the experiments relating LMI results to
HLA status and those comparing the B2 and fraction III
subtractions of gluten. Ashkenazi et al. (1980)
suggest that B2 gives superior results to gluten
fraction III in their aqar-drop system. In a direct
comparison between B2 and gluten fraction III (see
Figures 21 and 22) no correlation between results with
the two antigens was shown and in fact B2 produced no
significant inhibition of migration in any patient
studied. This is perhaps unsurprising as the
concentration of B2 used was almost certainly sub-
optimal for the capillary tube LMI test and dose-
response studies were precluded by the limited quantity
of material available. Nevertheless, Ashkenazi et al.
(1980) compared the optimal dose of B2 (established by
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dose-response studies) with a single arbitrary dose of
gluten fraction III in a direct agarose drop system to
reach their conclusion that B2 was superior. Perhaps
the only fair conclusion to be reached from the present
results is that comparisons between different antigenic
materials in any LMI system are unjustified unless full
dose-response and time-course experiments are included
so that optimal responses can be compared.
Of greater importance and interest are the
observations on the effects of HLA status on results of
the LMI test. One possible explanation for the high
prevalence of the HLA-B8 antigen in coeliac disease
(80% as against 20% in the general population (Falchuk
et al . 1972)) is that possession of HLA-B8 is
associated with an increased immune response to
gluten. As has been discussed, there is strong
evidence for specific immune response genes to a
variety of antigens in animals (including an H-2 linked
response to gluten in the mouse (Johnson et al .
1980)). In man the position is less clear as the
antigens used are in general complex and presumably
bear many antigenic determinants, unlike the synthetic
antigens used in most animal studies. However, HLA
status has been shown to be associated with altered
immune reactivity to a variety of antigens and genetic
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analysis in one study has indicated that a single gene
is involved despite the complex nature of the antigen
(Sasazuki et al. 1980).
In the present study, a clear increase in immunity
to gluten (as measured by the LMI test) is shown in
normal controls with HLA-B8 compared with those lacking
HLA-B8. This finding is consistent with the hypothesis
that there may be a single immune response gene for
gluten in linkage disequilibrium with HLA-B8 but does
not provide proof. Further studies, including large
family studies with genetic analysis such as that
performed by Sasazuki et al . ( 1980) are required to
further investigate this hypothesis.
The possible importance of the existence of such
an immune response (Ir) gene is seen when the results
of the coeliac patients are examined. Here there is no
difference in response between HLA-B8 coeliacs and
non-HLA-B8 coeliacs, and both show increased response
to gluten compared with non-HLA-B8 controls. This
implies that for coeliac disease to develop it is
necessary to have the putative Ir gene for gluten.
However, many normal controls having HLA-B8 presumably
also possess this putative gene which is thus not
sufficient for the development of coeliac disease
(though the observations of Doherty & Barry (1981) on
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gluten-induced small bowel changes in relatives of
coeliac disease patients may be relevant here). This
position is similar to that seen in HLA-1 inked immune
responses to ragweed pollen and the development of
clinical hay-fever (Levine et al. 1972). It is also of
interest that earlier studies of anti-gluten antibodies
(Scott et al . 1974 ) showed a similar pattern, with
increased titres in normals and non-coeliac disease
patients with HLA-B8 but no effect of HLA-B8 in coeliac
disease.
The influence of HLA-B8 on results of the LMI test
also has important implications when considering the
possible diagnostic use of the test. Current
enthusiasts for the L MI test as a diagnostic aid
(Ashkenazi et al. 1978; Ashkenazi et al. 1981;
O'Farrelly et al . 1982 ) have presented data from the
agarose drop method and the indirect LMI test comparing
coeliacs with normal controls. If HLA-B8 has an effect
on results of these assays then the demonstrated
differences may merely reflect the increased prevalence
of HLA-B8 in a coeliac population. Before these tests
can be accepted, it is thus necessary to re-evaluate
results with reference to the HLA status of the control
groups.
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HLA-DR3 is more closely associated with coeliac
disease than HLA-B8 and it is thus rather disappointing
that no significant increase in immune response to
gluten was shown in controls having this antigen. This
may merely reflect the smaller numbers studied.
The effect of gluten-exclusion on increasing
detectable immune reactivity to gluten of circulating
leucocytes in coeliac disease has been known for some
years (Holmes et al . , 1976 ; Bullen & Losowsky, 1978b).
Results from this study agree with earlier work and
have since been confirmed by work using the agarose
drop LMI test (Ashkenazi et al. 1981). The initial
fall in migration index (in the arbitrari1y-defined
early treated group) is consistent with the release of
committed g1uten-reactive lymphocytes from the gut
proposed by Holmes et al. (1976). Antigen-specific
trapping of lymphocytes in the gut has been
demonstrated in rats sensitised to cholera toxoid
(Pierce & Gowans, 1975). The later decline in immunity
has not previously been demonstrated and would suggest
a gradual reduction in the population of gluten-
reactive cells after prolonged lack of antigenic
stimulation.
The demonstration of the inverse relationship
between production of inhibitors of leucocyte migration
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by jejunal mucosa and in peripheral blood is also in
accord with the proposed shift of gluten-reactive cells
with changes in the diet. This inverse relationship
has not previously been directly demonstrated. As will
be discussed later, other explanations for the
phenomenon are possible.
One of the major problems of any immunological
investigation into a disease lies in deciding whether
any positive findings may be pathogenetically important
or are merely epiphenomena. As was mentioned in the
Introduction, early interest in the pathogenic role of
anti-gluten antibodies waned with the realisation that
non-coeliacs sometimes possessed this antibody and that
coeliacs often produced antibodies to a wide range of
dietary antigens. This last observation has been
explained by postulating "leakiness" of the damaged
mucosa in coeliacs with consequent increased exposure
of the immune system to dietary antigens (Ferguson &
Carswell, 1972; Asquith & Haeney, 1979). The
specificity of the LMI test with regard to antigen has
not previously been studied with a range of dietary
ant i gens.
The food antigens used in this study were chosen
in order to try and maximise the chances of obtaining a
positive result. Thus, antibodies to all antigens
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chosen are relatively common in coeliac disease (Kivel
et al.,1964; Kumar et al..1976; Ferguson & Carswell,
1972). Crude preparations of these foods were used as
similar preparations are usually used in antibody
studies and seem more likely to include the actual
antigens encountered in the diet than more purified and
homogeneous protein extracts. The use of bovine serum
albumin posed some problems because of potential
cross-reaction with the foetal calf serum used in the
culture medium. However, it was included in
preliminary studies as it has been found that there is
a considerably higher prevalence of antibody to BSA
than to foetal calf serum in coeliac disease (Kumar et
al.,1976). This is presumably due to reactions to
polymers found in commercially prepared BSA (Sol 1 i &
Bertolini, 1977) similar to those found in cooked meat
in the diet. It is known that polymerised or heated
BSA differs antigenically from native monomeric BSA
( Strachambova-McBride et al . 1980 ).
The observation that food antigens other than
gluten give similar results to gluten in the LMI test
weakens the argument that the test is measuring an
immune phenomemon which is important in pathogenesis.
It does not, of course, disprove the hypothesis as
positive results to the other antigens may be
epiphenomena whilst those to gluten may be important.
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The degree of immunity to egq and BSA shown by the
LMI test seems to correlate with the degree of mucosal
abnormality, decreasing as the mucosa improves. This
is similar to results of earlier antibody studies
(Kumar et al.,1976) and supports the concept of
"leakiness" of the mucosa as an explanation for the
findings. The different pattern of response to gluten
after starting treatment, with an early increase in
immunity both in antibody studies (Rossipal, 1974;
Scott, 1975; Stern et al.,1979a) and using the LMI
test, could suggest that gluten does differ from the
other antigens and that these immune reactions may be
pathogenetical 1 y important. This argument, however,
ignores the fact that the treatment is exclusion of
gluten from the diet and not exclusion of these other
antigens. The vital experiments of assessing the
response of normal controls to gluten-exclusion and of
coeliacs to the exclusion of one of the other dietary
antigens have not been performed.
The lack of response to milk antigen in this study
confirms previous work (Haeney & Asquith, 1978), though
a relatively low concentration of milk was used.
Higher concentrations did not produce toxicity but
plates were difficult to read because of cloudiness.
145
In this case there may be an argument for repeatinq the
studies using purified milk proteins such as lacto-
globulin.
The lack of effect of HLA-B8 on immune response to
these other dietary antigens is interesting. The
increased response to gluten seen with HLA-B8 could be
explained as merely a facet of the generalised increase
in immune responsiveness known to be associated with
possession of this antigen (Vladutiu & Rose, 1974) but
the lack of an increased response to these other
antigens makes this less likely. This suagests that
the response to gluten is specifically increased in
HLA-B8 individuals and may therefore be of some
pathogenetic significance. Interestingly, these
findings are again paralleled by earlier antibody
studies (Scott et al. 1976) where HLA-B8 was associated
with an increased titre of antibodies to gluten but not
to other dietary antigens.
The LMI test in coeliac disease has been widely
interpreted as giving a quantitative estimation of
ce11-mediated immunity to gluten or its subtractions.
Positive results have then been used to implicate a
type IV or delayed hypersensitivity reaction to gluten
in the pathogenesis of the mucosal lesion. However,
the original justification for the use of the LMI test
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as an assay of ce11-mediated immunity lies in the
correlation between results of the test and results of
skin tests for delayed hypersensitivity. Skin testinq
with gluten fractions in coeliac disease has not
supported the presence of delayed hypersensitivity
reactions, in contrast to the good correlation seen
between skin tests and LMI tests when antigens such as
PPD are studied for which the importance of cell-
mediated immunity is clear (Rauch & King, 1973;
Mitchell et a1. 1972; Rosenberg & David, 1970). Even
in these systems, however, there is considerable
evidence to show that the concept of an antigen
reactinq with a specifically sensitised T lymphocyte
which then releases a lymphokine which in turn inhibits
polymorph migration is an over-simp1ification and that
other mechanisms may play a part. Rocklin (1974)
showed that direct migration inhibition would occur in
a population of mononuclear cells with 10-15% added
polymorphs only if the polymorphs were derived from a
donor sensitised to the antigen used. This suggested
that some factor on the surface of the polymorphs
(possibly a cytophilic antibody) was participating in
the inhibition. Senyk & Hadley (1973) found that
purified mononuclear cells were unaffected in the LMI
test but that purified polymorphs were inhibited by
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antigen, again suggesting a role for cytophilic
antibody. Polymorphs may also be rendered susceptible
to non-specific (and presumably non-immuno1ogical)
inhibition. Clausen (1974) showed a transient
sensitivity to Brucella antigens without delayed
hypersensitivity in patients with streptococcal
tonsillitis. Inhibition of migration by factors other
than T-cell produced lymphokines has already been
discussed in the Introduction.
Several groups have demonstrated blocking of
migration inhibition by protein synthesis inhibitors
using antigens (BCG and PPD) accepted as lymphokine
producers (Rosenberg & David 1970; Gorski, 1974; Maini
et al . 1973 ). These results suggest that protein
synthesis is necessary for lymphokine-mediated
migration inhibition. The exact mechanism of action is
not understood, though there is some evidence to
suggest that the puromycin is acting on the target cell
to render it unresponsive to lymphokine rather than on
lymphokine release by the lymphocyte (Kotkes & Pick,
1975). The failure of puromycin to block inhibition in
this study thus argues against the role of lymphokines
in migration inhibition produced by gluten. The
concentration of puromycin used is similar to that used
in previous studies and is shown to be sufficient by
148
its effect on migration index to PPD in the Mantoux-
positive controls. The lack of effect with gluten is
in accord with earlier work showing that jejunal
biopsies from coeliac patients continued to produce
soluble inhibitors of leucocyte migration when cultured
with gluten despite the presence of puromycin (Howdle
et al. 1981).
The results of the LMI test performed with
purified sub-populations of leucocytes support the view
that a non-1ymphokine mechanism is involved.
Technically, these experiments are far more demanding
than the simple LMI test and the number of tests done
was much smaller. Nevertheless, the cell separation
techniques worked satisfactorily and results seem
clear. The demonstration that purified polymorphs from
coeliac patients are inhibited by qluten is strong
evidence against the role of lymphokine in producing
migration inhibition. No such inhibition was seen
using PPD in the Mantoux-positive subjects. The
addition of T-lymphocyte enriched cell suspensions
failed to increase the degree of migration inhibition,
again suggesting that lymphocyte products are not
involved. This again contrasts with the findings with
PPD where addition of the T-cell preparation produces
migration inhibition in the Mantoux-positive subjects.
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Furthermore, the correlation between results of the LMI
test performed in the standard way and that performed
with polymorphs alone suggests that, though lymphocyte
activation may occur with gluten in the context of this
test, it is not the major mechanism by which migration
inhibition occurs.
The sensitisation of normal leucocytes to gluten-
induced migration inhibition by pre-incubation with
serum from coeliac patients suggests that cytophilic
antibody may be involved. Inhibition of leucocyte or
macrophage migration by cytophilic antibody in the
presence of antigen has been shown by several groups of
workers (Heise et al.,1968; Kostiala & Kosunen, 1972;
Lockshin et al., 1973; Amos et al ., 1967 ; Wasserman,
1965 ; Ortiz-Ortiz et al . , 1974 ). The existence of
antibodies which bind to phagocytic cells and modify
their immune capabilities has been known for many years
(see review by Tizard, 1971). Most of the available
experimental data concern macrophage-cytophi1ic
antibody (Tizard, 1971; Berken & Benacerraf, 1966;
Nelson & Boyden, 1967) though similar antibodies which
bind to polymorphs and modify their antigen-binding and
phagocytic capabilities have been described in animals
(Fidalgo & Najjar, 1967; Watson, 1976) and there is
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some evidence that the Ig G subclasses Ig Gi and Ig G 3 in
man bind to polymorphs as well as to monocytes (Hay et
al ., 1972 ) .
Cytophilic antibody binds to cells via interaction
between its Fc portion and Fc receptors on the cell
surface (Berken & Benacerraf, 1966). The blocking of
the sensitisation of normal leucocytes by coeliac serum
by incubation in the presence of aggregated I g G (which
blocks Fc receptors) prior to exposure of the cells to
the coeliac serum supports the contention that cyto¬
philic antibody is involved. Immune complexes, also
reported to cause migration inhibition (Spitler et al.,
1969; Kotkes & Pick, 1975), are unlikely to be the
cause of the inhibition of the normal leucocytes as
their migration in control medium was unaffected by
incubation with coeliac serum, inhibition only being
seen when gluten was added.
The other experiment undertaken to investigate
possible other mechanisms of migration inhibition was
that involving rham nose. This showed no effect and
thus did not support the hypothesis that migration
inhibition may be mediated via a lectin-like binding of
gluten to the leucocyte cell surface. This does not,
of course, invalidate this hypothesis, but to do so
would require screening of a wide range of possible
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inhibitory sugars. As the only evidence available
(Douglas, 1976) suggests that rhamnose is the likely
sugar specificity of the putative lectin this seems a
reasonable starting point. Douglas1 results, however,
are unconfirmed and show certain unexplained features
(such as the increased binding shown with some other
sugars) and it is not clear that further investigation
is warranted in the absence of further supportive
background evidence.
How do these new observations on the mechanisms of
migration inhibition in the direct LMI test relate to
the conclusions shown from earlier published work and
the results presented earlier in this thesis? First,
it is essential to emphasise that these results must
only apply to the LMI test performed as described
here. There is no doubt that minor technical
variations can influence the results of the LMI test
considerably (Maini et al., 1973). Whether changes in
factors such as the method of isolation of the cells
(with possible consequent variations in the proportions
of various sub-populations of white cells in the final
cell preparation) might affect the mechanisms of
migration inhibition is not known. However, it does
seem possible that this may be so. There is certainly
evidence that varying the crude proportions of
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lymphocytes to polymorphs may affect the results
(Warrington et al . , 1976 ). However, results in the
present studies are similar to earlier work both as
regards the degree and prevalence of positive reactions
with gluten in coeliac patients and are consistent with
respect to the effects of dietary manipulation (Bullen
& Losowsky, 1978b; Haeney & Asquith, 1978). These
earlier results have all been interpreted as evidence
of cell-mediated immunity to gluten and this
interpretation must now be questioned. It is
interesting that the limited information available on
changes in anti-gluten antibody titres with dietary
changes seems to suggest parallel changes in titre to
the changes seen in L MI test results (Rossi pal, 1974;
Scott, 1975) and that humoral immune responses to
gluten but not to other dietary antigens seem to be
affected by possession of HLA-B8 in the absence of
coeliac disease, though anti-gluten titres are not
affected by HLA-B8 in coeliac patients (Scott et al.,
1974; Scott et al ., 1976 ). This is merely
circumstantial evidence and there is no reason to
suppose that titres of cytophilic antibodies would
exactly follow those of antibodies detected in more
conventional ways.
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There is, of course, still much evidence to
demonstrate that cell-mediated immunity to gluten
exists. The indirect L MI test results of O'Farrelly
et al. (1982) are impressive (though interestingly fail
to show any effect of gluten-free diet on results) and
this test has not been demonstrated to be affected by
factors such as immune complexes or cytophilic
antibody. However, suitable control experiments do not
seem to have been performed. Further studies of the
LMI test in any form should include studies to define
the mechanisms involved. As discussed in the
Introduction, the large number of lymphocyte
transformation studies give varying results and there
are some discrepancies in the time course of the
responses. Despite this, however, it does seem
probable that ce11-mediated immunity to gluten can be
demonstrated. Its exact relevance to pathogenesis,
especially in the absence of skin test delayed
hypersensitivity, remains uncertain. As for the
possible pathogenetic role of cytophilic antibody, it
is worth recalling the work of Ezeoke et al . ( 1974)
suggesting that ADCC may be involved in producing
jejunal mucosal damage and this approach merits further
study.
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It is also noteworthy that very recent work
(Verkasalo, 1982) has demonstrated binding of a g1iadin
subtraction to 25-65% of B lymphocytes (i.e. those
bearing surface immunoglobulin) from treated coeliac
patients. Binding was unaffected by HLA status (though
one normal control with DR3 showed 34% binding) and it
was felt that it was improbable that such a large
proportion of cells would be synthesising anti-gluten
antibody. It is tempting to speculate that this
binding could be mediated via cytophilic antibody on
the surface of K cells which would segregate with B
cells on density-gradient centrifuqation.
Interpretation of the effect of diet on LMI
results in the light of the present studies merely
requires the assumption that the relevant antibody is
fixed in the gut when a gluten-containing diet is taken
and is released into the blood in increased quantity
after a gluten-free diet is started. Results of the
indirect LMI test with cultured jejunal biopsies are
more difficult to explain. They may represent antibody
synthesis in the mucosa of untreated coeliacs. Culture
with gluten seems unlikely to increase release of free
antibody but it is possible that immune complexes are
formed and elute into the medium to be measured in the
indirect test. This is highly speculative but is at
least open to experimental investigation.
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So far as studies with the other dietary antiqens
are concerned, there is no information as to whether
these too are producing migration inhibition via
cytophilic antibody or by another mechanism.
Jejunal biopsy culture studies
The studies reported in this thesis represent a
preliminary effort to utilise the potential of the
jejunal biopsy culture technique to elucidate possible
immunoloqical or other mechanisms of qluten-induced
mucosal damage. Previously only Falchuk, Gebhard &
Strober (1974) in their experiments involving
co-culture of biopsies from untreated and treated
coeliac patients and Katz et al. (1976) and Bramble et
a1 . (1981) using steroids, have used this approach.
Much of the difficulty involved in using the
system is in deciding what parameter should be used to
quantify the degree of mucosal damage. Biochemical
methods have been widely used with conflicting
results. Falchuk's group in the U.S.A. have had
considerable success using this method (Falchuk et al.,
1974; Katz & Falchuk, 1978; Katz et al., 1976; Katz &
Falchuk, 1978; Falchuk et al., 1980) and claim they can
diagnose coeliac disease reliably. In other hands,
however, results are less impressive. Hauri et al.
( 1978 ) and Howdle et al . (1981b) showed similar
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increases in alkaline phosphatase activity of cultured
biopsies from coeliac patients but could not
demonstrate any effect of gluten. Other workers
(Mitchell et al., 1974; Stevens et a1., 1978) could not
demonstrate any change in alkaline phosphatase, though
Mitchell et al. (1974) showed an increase in enzyme
activity in the culture medium. The explanation for
these discrepancies is not clear. Minor differences in
the technique of the biopsy culture may be responsible,
but a more likely explanation has been suggested by
Howdle et al . ( 1982 ). These workers point out that
Falchuk's group have studied mainly children and
adolescents, whereas other workers have mainly studied
adult coeliacs and suggest that in vitro gluten
sensitivity may be a function of age. They also point
out that the known morphological patchiness of the
mucosal lesion in coeliac disease (Scott & Losowsky,
1976c) may well be accompanied by varying gluten
sensitivity of different areas of the mucosa.
Falchuk's group culture separate biopsies in culture
whereas Howdle et al . compare pieces cut from the same
biopsy and cultured in different conditions.
In view of the these varied findings it is perhaps
not surprising that alkaline phosphatase levels in the
present study did not demonstrate any significant
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effects of culture with gluten and lymphocytes. Mean
pre- and post-culture values of alkaline phosphatase
activity were similar to those reported by other
workers and the rise in activity with culture is also
shown. The lack of any effect of gluten alone is in
accord with all previous work which shows the relative
insensitivity of treated coeliac mucosa to in vitro
damage. The various methods of expression of results
do not affect these conclusions.
Of much greater interest are the results of the
studies using guantitative histology to assess mucosal
dam age. These demonstrate that the combination of
gluten and autologous peripheral blood mononuclear
cells can produce significant mucosal damage to jejunal
biopsies from treated coeliac patients in vitro. The
damage produced is greater than that produced by
culture with either gluten or lymphocytes alone,
suggesting that there is some synergistic effect. The
lack of effect of this combination on the cultured
biopsies from non-coeliac patients suggests that the
effect is specific to coeliac disease.
The demonstration of significant effects by use of
guantitative histology in the absence of changes of
alkaline phosphatase activity is in accord with recent
published work, which suggests that histological
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methods may be more sensitive than biochemical methods
(Howdle et al., 1981a). In this study great care was
taken in the technique of measuring enterocyte height
and the method undoubtedly gives reproducible results.
On the basis of the reproducibility studies one can
calculate that changes in enterocyte height of more
than around 1.3y are unlikely to arise from observer
error. This would represent a change of about 5% in
enterocyte height. Both gluten alone and lymphocytes
alone did produce small reductions in enterocyte height
(of around 3%) which were not statistically
significant. The 9.1% reduction produced by the
combination of qluten and lymphocytes is significant
compared with both biopsies cultured in control medium
and those cultured with gluten or with lymphocytes
alone. If, however, the changes produced by gluten
alone and by lymphocytes alone are added, then that
produced by the combination no longer differs
significantly, though the mean change is almost double
(t = 0 . 542 , p>0.1). The case for synergy rather than
merely an additive effect of two separate non-
spec ifically noxious influences thus remains not proven
by these experiments. Nevertheless, the relative
magnitude of the changes seen and the lack of an effect
in the non-coeliac biopsies suggests that some
synergistic effect is occurring.
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The lack of a significant toxic effect of gluten
alone conflicts with the results of Howdle et a 1 .
(1981a) who showed a 5% reduction in enterocyte height
in biopsies from treated coeliac patients cultured with
gluten fraction III. This difference does not seem to
be explicable on the basis of patients at different
stages of treatment, as the mean pre-culture enterocyte
height of patients in the two studies is very similar.
Two factors are probably important: (1) the smaller
numbers in the present study and (2) the fact that
Howdle et al. were comparing pieces from single
biopsies which were cut into two and cultured with and
without gluten. The increased number of culture
conditions in the present study precluded such an
approach, necessitating comparisons between biopsies
from different sites and thus possibly reducing the
precision of the method.
The increased sensitivity to gluten of the
biopsies cultured with lymphocytes fits nicely with the
hypothesis that the number of gluten-reactive
lymphocytes in the jejunal mucosa declines when gluten
is excluded from the diet and these cells are then free
to circulate in the blood. Co-culture of biopsies and
peripheral blood lymphocytes then allows the
lymphocytes to react with the gluten peptides and
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damage the mucosa. There are several possible
mechanisms by which the lymphocytes may produce mucosal
damage. These include generation of cytotoxic T cells,
production of lymphokines and antibody-dependent
cellular cytotoxicity (ADCC). Cytotoxic T cells are
activated by cell-surface determinants (including
histocompatibility antigens) (Zinkernagel & Doherty,
1979) and damage by such a mechanism would presuppose
binding of the gluten peptide to the cell surface. Of
the numerous lymphokine activities described,
lymphotoxin is directly toxic to cultured cell lines.
Lymphokine-mediated damage does not necessarily involve
binding of gluten to the enterocyte, which may be
damaged as an 11 innocent bystander" as described in
graft-versus-host disease (Elson et al.,1977).
ADCC also involves binding of the peptide to the
enterocyte surface. Specific antibody then binds to
the peptide and a variety of cells with receptors for
the Fc portion of the antibody molecule (including
macrophages, polymorphs and the small 1 ymphocyte-1ike K
cell) may then be involved in producing the cytotoxic
effect (Roitt et al.,1976). None of these mechanism
involve complement, which was not present in the
culture system in these studies. The present results
are consistent with any of these mechanisms and further
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experiments involving culture with sub-populations of
lymphocytes, with protein-synthesis inhibitors to block
lymphokine action and with addition of aggregated I g G
to block ADCC are needed to define the mechanism
further. The studies of Falchuk et al . ( 1974 )
involving co-culture of biopsies of untreated and
treated coeliacs are also relevant. These suggested
that a soluble mediator was involved and would support
1ymphokine-mediated or ADCC mediated damage.
It is also interesting to speculate on how the
results discussed earlier relating to the mechanisms of
the LMI test may fit in. These would support the
concept of coeliacs possessing antibody to gluten
capable of binding to cells known to be involved in
ADCC. In addition, the work of Ezeoke et al . ( 1974)
and the nature of the early histological changes seen
after gluten challenge (Anand et al., 1981) would
suggest that greater attention be paid to ADCC as a
possible pathogenetic mechanism in coeliac disease.
The lack of correlation between the degree of
damage produced by culture with gluten and lymphocytes
and the result of the LMI test could have several
explanations. It may merely be that the two methods
are so imprecise that any correlation is missed.
Alternatively, if the LMI test is measuring cytophilic
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antibody mainly on polymorph cell membranes then it is
not surprising that results do not correlate with the
putative cytotoxic effects of blood mononuclear cells,
which may either have a different affinity for the
cytophilic antibody or may be exerting their effect
through another mechanism. If cytophilic antibody is
involved, it may be being synthesised in the mucosa and
the added lymphocytes may merely provide a source for
recruitment of effector K cells. Clearly there is
great scope for further experimentation in this field
to define the mechanisms involved.
The negative results of the experiments involving
assay of phosphatidyl inositol in cultured jejunal
biopsies are perhaps not surprising, for several
reasons. First, the assay itself is relatively complex
and considerable difficulty was encountered in
modifying it for use in an organ culture system, though
the final system did seem to give fairly consistent
results. Second, as no satisfactory system exists for
culture of isolated enterocytes the assay had to be
applied to cultured biopsies. As all cell membranes
metabolise phospholipids, any small change confined to
the enterocytes is liable to be swamped by the
background turnover in all the other cells in the
biopsy. Finally, the original postulate, i.e. that a
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lectin-like binding of gluten to the enterocyte
membrane might affect turnover of this lipid, may be
incorrect. Nevertheless, the experiments do
demonstrate that the jejunal biopsy culture system can
be used to study aspects of cell-membrane metabolism
and it is possible that this approach may yield
significant results in coeliac disease. This would be
made much more likely if a reliable culture system for
isolated enterocytes were developed.
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CONCLUSIONS
Several important conclusions can be drawn from
the work presented in this thesis.
1) Results of the direct LMI test are influenced by
the histocompatibility antigen HLA-B8 in a way
which suggests that an increased immune response
to gluten (or even an immune response gene for
gluten) may be necessary but is not sufficient for
development of the disease. The test should not
be used diagnostically without allowance for the
effect of HLA-B8.
2) Results are affected by diet in a manner
compatible with the theory of sequestration of
gluten-reactive cells or antigluten antibody in
the gut by gluten in the diet, release of these by
gluten exclusion and later decline in immunity
after prolonged antigen exclusion.
3) Positive results with the LMI test in coeliac
disease are not only found with gluten but also
with other dietary antigens - a position similar
to that found with serum antibodies. This weakens
the argument for the pathogenetic importance of
such responses.
4) The direct LMI test is not an index of T cell
mediated immunity but seems primarily to measure
cytophilic antibody.
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5) Co-culture of jejunal biopsies from treated
coeliacs with autologous lymphocytes restores
gluten sensitivity in vitro - a finding compatible
with the theory outlined in (2) and supporting the
role of immunity to gluten in pathogenesis.
6) No support is found for the lectin theory of
toxicity.
It is customary to end the discussion of a body of
research results with an attempt to combine any new
results with available information in an all-
encompassing theory. However, though the conclusions
above can be drawn from the results presented in this
thesis, I do not feel that further theorizing is
particularly helpful. If abnormal immunity to gluten
is a central pathogenetic mechanism in coeliac disease,
and this is not yet proven, then it is likely that the
abnormality will involve more than one of the possible
immune mechanisms discussed in the Introduction and,
most likely, the relative importance of the different
mechanisms will be different at different stages in the
natural history of the disease. The results presented
here draw attention to one potential immunopathogenic
mechanism which has perhaps been rather neglected by
investigators, and also demonstrate that the organ
culture system may be useful in investigating the
mechanisms involved.
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Of possibly greater importance, however, is the
demonstration that immunological tests cannot be
assumed to have the same basis in one disease as they
have been shown to have in another, and that it is
necessary to go back to basic immunological methods to
avoid misinterpretation of results which, in the long
run, may hamper rather than help our understanding of
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Appendix Table 1
Duplicate results of original assay for PI turnover
(cpm/mg)



























Duplicate results for modified assay for PI turnover
(dpm/mg protein)
Duplicate 1 Duplicate 2






89 .0 87 .0
126.8 119.4
90.1 87 .0





























Quench curve for PI turnover assay
N = No pxp(Q-693t)
( t )
. . 209,500 = No. 1.1187




m i n u t e ( S D )
Standard .6568 67739.8(0.2)
+ 1m1 CCI4 .6391 65079.0(0.2)
+ 2 " .6069 61545 .0(0 .2 )
+ 3 .5962 58349.5(0.2)
+ 4 .5675 54351.5(0.2)
+ 5 .5361 50658.5(0.2)
+ 6 .5160 47266 .5 (0 .3 )
+ 7 .4846 44339.5(0.3)
+ 8 " .4479 41584.5(0.3)
+ 9 " . 4295 38800.0(0.5)
+ 10 .4106 36930.0(0.5)
+ 11 . 3669 33306.0(0.5)




























































































































Allpost-culturegro pshavesignificantlyloweentero .yteheight thanepre-culturev l es(p<0.001)
Appendix Table 5
AP/mg prot.
PATIENT PRE C CL G GL
1 45 .9 88.2 151.3 90.2 85 .4
2 55.2 111.8 82 .9 149 .4 81.2
3 31.6 33 .7 56.4 29.5 44.6
4 26 .6 84.3 63.7 101 .7 105.4
5 15.5 26.3 24.3 50.7 45 .2
6 cc1—1 87 .1 70.3 26.7 32 .5
7 65 .6 56 .6 17.3 38.6 14.1
8 32 .8 49. 1 79.4 50.5 38.5
9 20.7 64.8 93.9 43.0 64.7
10 79.4 58.1 78.1 76.1 67 .2
11 57.6 40.9 59 .8 34.0 65 .3
12 35 .3 63 .9 46.2 75 .7 66.5
13 13.6 13.2 11.0 10.6 4.4
MEAN 38.3 59 .9 64.2 59.8 55 .0
SD 20.8 27.9 36 .9 37 .9 28.6
Appendix Table 6
AP/mg. wet wt.
PATIENT PRE C CL G GL
1 1.46 2.54 4.34 2.15 2.51
2 1.37 2.51 3.19 2.32 1.21
1 3 1.24 1.38 2 .58 2.12 3.33
4 1.32 2.91 3.53 4.68 4.48
5 0.37 0.37 1.01 1.18 0.79
6 1.33 3.97 3.25 1.29 1.19
7 1.25 2 .59 1.33 2.15 1.17
8 1.64 2 .90 4.92 3.30 1.92
9 0.80 1 .80 1.88 0.88 2.61
10 2.63 2 .88 2.88 3.29 3.18
11 2 .30 1.46 1.79 0.63 1.37
12 2 .00 3.34 2.10 4.37 5.76
13 0.52 0.56 0.80 0.77 0.36
MEAN 1.40 2.25 2.58 2 .24 2.30
SD 0.65 1.07 1.26 1.33 1.57
Appendix Table 7
AP/y g DNA
PATIENT PRE C CL G GL
1 1.43 1.64 3.88 1.93 0.65
2 1.65 2 .83 2 .00 3.52 1.23
3 0.85 0.54 1.46 0.77 0.60
4 1.83 1.93 3.13 3.51 3.58
5 0.85 0.71 0.90 2 .28 1.34
6 2 .32 3.78 3.06 3.36 3.56
7 1.07 1 .20 0.71 1.05 0.30
8 0.89 1.26 1.74 1.21 0 .88
9 0.66 1.03 1.78 0.94 1.16
10 1.10 1.36 1.86 1.40 1.40
11 0.96 0.57 1.37 0.35 0.83
12 1.46 2 .20 1.63 3.35 4.09
13 0.40 0.62 0.60 0.41 0.08
MEAN 1.19 1.51 1 .86 1.85 1.52
SD 0.53 0.97 0.98 1.22 1.33
